| 1 |
| 00:00:00,610 --> 00:00:05,670 |
| ุงููู ุงูุฑุญู
ู ุงูุฑุญูู
ุญุถุฑุชูุง ุงูููู
ุนู tumor |
|
|
| 2 |
| 00:00:05,670 --> 00:00:12,070 |
| immunology ูู
ุดุงุฑุฌ |
|
|
| 3 |
| 00:00:12,070 --> 00:00:17,990 |
| ุฌูุงุฒ ุงูู
ูุงุนุฉ against tumor cell ุทุจุนุง ูููุง ุจูุนุฑู ุงู |
|
|
| 4 |
| 00:00:17,990 --> 00:00:27,770 |
| tumor cell has antigen on their surface ูุจุงูุชุงูู |
|
|
| 5 |
| 00:00:27,770 --> 00:00:36,130 |
| these antigens are foreignantigen ูุจุงูุชุงูู |
|
|
| 6 |
| 00:00:36,130 --> 00:00:43,430 |
| ุงูุฌุณู
ุจูุนุชุจุฑูุง as foreign cells ููุงุจุฏ ู
ู ุงูู ูุดูุฑ |
|
|
| 7 |
| 00:00:43,430 --> 00:00:54,770 |
| ููู ุชุตุฏู ููุฐู ุงูุฎูุงูุง ุงู |
|
|
| 8 |
| 00:00:54,770 --> 00:00:55,730 |
| tumor specific |
|
|
| 9 |
| 00:00:58,510 --> 00:01:02,690 |
| transplantation antigen ูู ุงูุงูุชุฌูุงุช ุงูุชู ุชุธูุฑ ุนูู |
|
|
| 10 |
| 00:01:02,690 --> 00:01:07,830 |
| ุณุทุญ ุฎูุงูุง tumor ููุฌุฏููุง |
|
|
| 11 |
| 00:01:07,830 --> 00:01:12,390 |
| in variety of animal species tumor specific |
|
|
| 12 |
| 00:01:12,390 --> 00:01:17,830 |
| transplantation antigen ูุงู ูู
ุฎุด ุนูู ุชุนุฑููุงุช ูุฐู |
|
|
| 13 |
| 00:01:17,830 --> 00:01:23,870 |
| ุงูุงูุชุฌูุงุช tumor antigen ู
ู
ูู ุชุดุชุฑู ู
ุน ุงู tumor |
|
|
| 14 |
| 00:01:23,870 --> 00:01:24,290 |
| cell |
|
|
| 15 |
| 00:01:28,020 --> 00:01:33,300 |
| ุชุดุชุฑู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู |
|
|
| 16 |
| 00:01:33,300 --> 00:01:35,480 |
| ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู |
|
|
| 17 |
| 00:01:35,480 --> 00:01:35,880 |
| ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู |
|
|
| 18 |
| 00:01:35,880 --> 00:01:39,600 |
| ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู |
|
|
| 19 |
| 00:01:39,600 --> 00:01:43,560 |
| ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู |
|
|
| 20 |
| 00:01:43,560 --> 00:01:44,340 |
| ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู |
|
|
| 21 |
| 00:01:44,340 --> 00:01:50,080 |
| ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู |
|
|
| 22 |
| 00:01:50,080 --> 00:01:55,800 |
| ู
ุฎุชูู ุจุดูู ู
ูู Demonstration of Tumor-Specific |
|
|
| 23 |
| 00:01:55,800 --> 00:01:59,980 |
| Antigen of Chemically Induced Tumor ุฃูู ู
ุง ุงูุชุดููุง |
|
|
| 24 |
| 00:01:59,980 --> 00:02:06,400 |
| ุฑุฏุฉ ูุนู ุฌุณู
ุงูู
ูุงุนูุฉ ูู ุงู .. against tumor |
|
|
| 25 |
| 00:02:06,400 --> 00:02:15,560 |
| antigen ู
ู ุฎูุงู ุชุฌุฑุจุฉ ุนูู ุงู mice ุงูุชุฌุฑุจุฉ ูุงูุช |
|
|
| 26 |
| 00:02:15,560 --> 00:02:25,710 |
| ูุงููุงุชู ุนู
ููุง tumorูู ุงูู mouse ู
ู ุฎูุงู ุฏูู ุงู |
|
|
| 27 |
| 00:02:25,710 --> 00:02:32,450 |
| skin of the mouse by methyl chloranthrene ูุจุงูุชุงูู |
|
|
| 28 |
| 00:02:32,450 --> 00:02:38,730 |
| ุงุณุชููู ุงู tumor they excise the tumor ูุนู
ููุง ู
ูู |
|
|
| 29 |
| 00:02:38,730 --> 00:02:44,990 |
| tumor cell suspension ู ุจุนุฏ ููู they inject the |
|
|
| 30 |
| 00:02:44,990 --> 00:02:50,220 |
| prepared tumor cell into a new mouseุฃูุถุง ุชูููุช |
|
|
| 31 |
| 00:02:50,220 --> 00:02:57,060 |
| tumor , they excise the tumor ู they challenge the |
|
|
| 32 |
| 00:02:57,060 --> 00:03:02,660 |
| mouse with the same tumor ูุฌุฏูุง ุงูู there is no |
|
|
| 33 |
| 00:03:02,660 --> 00:03:03,760 |
| tumor growth |
|
|
| 34 |
| 00:03:07,990 --> 00:03:11,330 |
| Injection of repaired tumor cell into a new |
|
|
| 35 |
| 00:03:11,330 --> 00:03:17,910 |
| mouseExercise a growing tumor ุฃูุถูุง Challenge with |
|
|
| 36 |
| 00:03:17,910 --> 00:03:22,510 |
| different tumor cells With tumor cells ูุญู ุงูู |
|
|
| 37 |
| 00:03:22,510 --> 00:03:30,630 |
| tumor will grow ุจุจุณุงุทุฉ ุฎุทูุงุช ุงูุชุฌุฑุจุฉ ูุงูุช ูุงูุขุชู |
|
|
| 38 |
| 00:03:30,630 --> 00:03:36,070 |
| ุฐูุฑูุงูุง ุฅูู
ุง ูุดุฑุญูุง ุนูู ุตูุฑุฉ ูุงูุขุชู ูู ุนุจุงุฑุฉ ุนู |
|
|
| 39 |
| 00:03:36,070 --> 00:03:40,500 |
| mousewith chemically carcinogenic induced tumor |
|
|
| 40 |
| 00:03:40,500 --> 00:03:48,180 |
| ุฏูุงููุง ุฏู ูู ุงู skin by ash ุงููู ูู carcinogenic |
|
|
| 41 |
| 00:03:48,180 --> 00:03:53,940 |
| agent ูุชููู ุงู cancer ุฃุฎุฏูุงูุง ู ุนู
ููุง ู
ููุง tumors |
|
|
| 42 |
| 00:03:53,940 --> 00:04:00,240 |
| cell suspension ูุทุจุนุง |
|
|
| 43 |
| 00:04:00,240 --> 00:04:08,550 |
| ุญูููุงูุง ูููุนู ู
ุงุดู the samethe same mouse ุญูููุง |
|
|
| 44 |
| 00:04:08,550 --> 00:04:17,410 |
| ุงูู ุซู
ุฑุฌุนูุง ุชุงูู ู ุญุทููุง ุงูู tumor cell ูุฌุฏูุง ุงู |
|
|
| 45 |
| 00:04:17,410 --> 00:04:26,890 |
| ุงู tumor cell ูู
ุชูู
ู ุฏููู ุนูู ุงู ุงู tumor cell |
|
|
| 46 |
| 00:04:26,890 --> 00:04:31,490 |
| ุงููู ุฏุฎูุช ุชุตุฏู ููุง ุฌูุงุฒ ุงูู
ูุงุน ู ููู ุงู vector |
|
|
| 47 |
| 00:04:31,490 --> 00:04:37,790 |
| cellุนู
ููุง ุงู tumor ู
ุฑุฉ ุชุงููุฉ ุงู tumor has been |
|
|
| 48 |
| 00:04:37,790 --> 00:04:44,210 |
| rejected the same cell ูู tumors ุงูุญูููุง for |
|
|
| 49 |
| 00:04:44,210 --> 00:04:57,290 |
| syndromic mice ุจุณ ูู ูุฐู ุงูุญุงูุฉ ูู
ุง ูู
ุง ูุนูู ุนู
ููุง |
|
|
| 50 |
| 00:04:57,290 --> 00:05:04,330 |
| ุชููู ุงู tumorููู ูู
ุงุฐุงุ ูุฃูู ูู
ูุฑู ุงูู tumor ู
ู |
|
|
| 51 |
| 00:05:04,330 --> 00:05:09,650 |
| ูุจู ูุฐุง ุงูู mouse ููู ูู ุฃุฎุฏูุง ุงูุฎูุงูุง ุงูู
ูุนูุฉ |
|
|
| 52 |
| 00:05:09,650 --> 00:05:12,950 |
| ุงูุชู ุชุชูููุช ุฌูุงุฒ ุงูู
ูุน ุงุดุชุบู ู ุฃุฎุฏูุง ุงูุฎูุงูุง |
|
|
| 53 |
| 00:05:12,950 --> 00:05:18,430 |
| ุงูู
ูุนูุฉ ุงูุชู ุชูููุช ุนูุฏู ู ุญูููุง ูู fire ุชุงูู ู
ู |
|
|
| 54 |
| 00:05:18,430 --> 00:05:22,770 |
| ุฎูุงู ุฏู ูู adoptively transfer T cell ุฎุฏูุง ุงูุฎูุงูุง |
|
|
| 55 |
| 00:05:22,770 --> 00:05:24,790 |
| ุงูู
ูุนูุฉ ุงูู
ุชู
ุซูุฉ ุจุงูู telepathy |
|
|
| 56 |
| 00:05:28,050 --> 00:05:31,230 |
| ุนู
ููุง challenge ูุนูู ุงุนุทููุง .. ูููููุง tumor ุนูุฏู |
|
|
| 57 |
| 00:05:31,230 --> 00:05:35,490 |
| ู
ุฑุชุงู ูุนูู ููุงูู ุงู tumor has been eradicated |
|
|
| 58 |
| 00:05:35,490 --> 00:05:41,810 |
| ุจู
ุนูู ูู
ุชูู
ู ูุฐู ุงูุฎูุงูุง ูุนูู ุงููุงุฑู ุงููู ุนูุฏู |
|
|
| 59 |
| 00:05:41,810 --> 00:05:44,970 |
| tumor ูู
ุง ูุฎููุงู ุจุงูุงุฏุงุก .. ุจุงู .. ุจุงู .. ุจุงู team |
|
|
| 60 |
| 00:05:44,970 --> 00:05:51,170 |
| for science ุงููู ุงุชูููุช ุนูุฏู ู
ุงุดู ูุฏู ูู ุนูู ุทูู |
|
|
| 61 |
| 00:05:51,170 --> 00:05:59,070 |
| ุตุงุฑ ูู eradication ุงูุฃู
ูู ูู tumor ุงููู ู
ูุฌูุฏุฏููู |
|
|
| 62 |
| 00:05:59,070 --> 00:06:03,650 |
| ุนูู ุงู ูู ุฌูุงุฒ ู
ููุง ูุงุนุฏ ุจูุดุชุบู ูุงูู ูู ุนูุงูุฉ |
|
|
| 63 |
| 00:06:03,650 --> 00:06:10,910 |
| ู
ุซุจุชุฉ ุจูู ุงู immune response ู tumor cell tumor |
|
|
| 64 |
| 00:06:10,910 --> 00:06:17,930 |
| immunology ูุฏุงููุง ูู ู
ุนุฑูุฉ ุงูุนูุงูุฉ ู
ุง ุจูู ุงู host |
|
|
| 65 |
| 00:06:17,930 --> 00:06:22,890 |
| and tumor ุงูุถุง using the immune response to tumor |
|
|
| 66 |
| 00:06:22,890 --> 00:06:29,050 |
| for diagnosis for prophylaxis and for therapyูู |
|
|
| 67 |
| 00:06:29,050 --> 00:06:36,330 |
| ุงูุงูุชุฌูู ุทุจุนุง ููููุฉ ุชูููููุง ุจุชู
ู ุฎูุงู mutation |
|
|
| 68 |
| 00:06:36,330 --> 00:06:42,550 |
| genetic activation clonal amplification |
|
|
| 69 |
| 00:06:42,550 --> 00:06:48,910 |
| chromosomal deletion and translocationูููุง ุนุจุงุฑุฉ |
|
|
| 70 |
| 00:06:48,910 --> 00:06:53,730 |
| ุนู ุนู
ููุงุช ุจุชุคุฏู ุฅูู mutation ูุจุงูุชุงูู ุจุชูููู ู |
|
|
| 71 |
| 00:06:53,730 --> 00:06:57,550 |
| tumor antigen some tumor antigen are unique to |
|
|
| 72 |
| 00:06:57,550 --> 00:07:02,510 |
| cancerous ูุนูู ููุท ู
ูุฌูุฏุฉ ุนูู ููุงูุง ุงูุณุฑุทุงููุฉ ู |
|
|
| 73 |
| 00:07:02,510 --> 00:07:09,110 |
| otherูู ู
ุดุงุจูุฉ ูู tumor cell antigen ูุนูู ู
ูุฌูุฏ |
|
|
| 74 |
| 00:07:09,110 --> 00:07:16,270 |
| ุจุชุดุจูู ุงููู ูู ุงูุด ุงู ุงู normal cell antigen ููููุง |
|
|
| 75 |
| 00:07:16,270 --> 00:07:22,170 |
| ุจุชุบุทู ุงูุฎูุงูุง ุชุบุทูุฉ ูุงู
ูุฉ ุงู ุฌุฒุฆูุฉ and these |
|
|
| 76 |
| 00:07:22,170 --> 00:07:29,430 |
| either by more expression on cancer cellsููู ุตุงุฑ |
|
|
| 77 |
| 00:07:29,430 --> 00:07:32,710 |
| ููู expression ุฒูุงุฏุฉ ุนู ุงููุงุฒูู
ููุฐู ุงูุงูุชูุฌูุงุช |
|
|
| 78 |
| 00:07:32,710 --> 00:07:38,010 |
| ุนูู ุงูุณุทุญ ุงูุฎููุฉ ุงูุณุฑุทุงูู ูุงู
ุซู ุนูู ุฐูู ูุซูุฑ ู
ููุง |
|
|
| 79 |
| 00:07:38,010 --> 00:07:41,470 |
| ุงู human epidermal growth factor ุงูุฑูุณุจุชูุฑ ุงููู |
|
|
| 80 |
| 00:07:41,470 --> 00:07:45,370 |
| ุจูุฒูุฏ ุงู expression ุชุจุนู ูู ุงู ovarian and breast |
|
|
| 81 |
| 00:07:45,370 --> 00:07:51,190 |
| cancer ุจุนุถ ุงู tumor antigen are present on |
|
|
| 82 |
| 00:07:51,190 --> 00:07:55,170 |
| embryonic cell ููููุง ู
ุด ู
ูุฌูุฏุฉ ุนูู ุงู normal other |
|
|
| 83 |
| 00:07:55,170 --> 00:08:01,190 |
| cells ุฒู ุงู oncofetal antigenุทู
ูุฑ ุงูุงูุชุฌูู ูู
ูู ุฃู |
|
|
| 84 |
| 00:08:01,190 --> 00:08:05,850 |
| ูููู ู
ุตุงุฏุฑ ู
ู ุงูุฌูุฉ ุงูู
ุชูุณุทุฉ ุฃูุถุง ุฏููู ุนูู ุงูู ูู |
|
|
| 85 |
| 00:08:05,850 --> 00:08:10,610 |
| ู
ููุนุงุช ุญุฑุงุฑุฉ ููุชุบููุฑ ูููุงู |
|
|
| 86 |
| 00:08:10,610 --> 00:08:11,710 |
| ูููู ู
ู ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
| 87 |
| 00:08:11,710 --> 00:08:12,030 |
| ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
| 88 |
| 00:08:12,030 --> 00:08:14,290 |
| ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
| 89 |
| 00:08:14,290 --> 00:08:14,990 |
| ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
| 90 |
| 00:08:14,990 --> 00:08:15,510 |
| ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
| 91 |
| 00:08:21,440 --> 00:08:24,420 |
| ุงูุชู ุชุณุจุจ ูู ุชุญููู ุงูุชู
ุฑ ุจุดูู ุฎุงุทุฆ ู
ุซู ุงูู |
|
|
| 92 |
| 00:08:24,420 --> 00:08:30,680 |
| Ultraviolet ูุงูู X-ray ุฅุฑุงุฏูุงุดู ูุงุฑุณูููุฌูู ูู
ูู ุฃู |
|
|
| 93 |
| 00:08:30,680 --> 00:08:35,840 |
| ูุณุจุจ ููู ุชุญููู ููููู ูุงุฑุณูููุฌูู ูุนู
ู ุชุญููู ููููู |
|
|
| 94 |
| 00:08:35,840 --> 00:08:42,000 |
| ูุฌุณูู
ูู ููุท ุงููู ุจุณุจุจ ุชุญููู ุฌููุงุช ูู
ุชูุฆ ู
ุตุงุฏุฑ |
|
|
| 95 |
| 00:08:42,000 --> 00:08:42,320 |
| ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ |
|
|
| 96 |
| 00:08:42,320 --> 00:08:43,620 |
| ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ |
|
|
| 97 |
| 00:08:43,620 --> 00:08:45,860 |
| ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ |
|
|
| 98 |
| 00:08:45,860 --> 00:08:50,670 |
| ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑุจุชุคุฏู ุงูู ุงูุด |
|
|
| 99 |
| 00:08:50,670 --> 00:08:57,930 |
| ุนู
ูุฉ clonal amplification ูุฎููุฉ ู
ุงุดู ููุด ูุฃูู |
|
|
| 100 |
| 00:08:57,930 --> 00:09:04,150 |
| ุงูุฌููุงุช ุงููู ุจุชุญุชูู ุนูู ุชูุฑุน ูุงุญุฏุฉ ู
ุงุดู ูู ุงููู |
|
|
| 101 |
| 00:09:04,150 --> 00:09:08,110 |
| ุนู
ูุช clonal amplification carcinogen ู
ุฑุฉ ุชุงููุฉ |
|
|
| 102 |
| 00:09:08,110 --> 00:09:14,550 |
| ุจูุคุฏู ุงูู mutation ู
ุงุดู of genesูุจุงูุชุงูู ูุฐู |
|
|
| 103 |
| 00:09:14,550 --> 00:09:19,170 |
| ุงูุฌููุงุช ุงูุชู ุชุญู
ู ุจููุง ุจูุงุณุทุฉ ุฎูุงูุง ู
ุนููุฉ ุชุฏูู |
|
|
| 104 |
| 00:09:19,170 --> 00:09:22,870 |
| ูููููุฉ ุงู amplification of the single cell |
|
|
| 105 |
| 00:09:22,870 --> 00:09:28,450 |
| ุงูู
ุชุญุณุณุฉ ููู
ููุชูุดู tumor antigen are well |
|
|
| 106 |
| 00:09:28,450 --> 00:09:33,330 |
| demonstrated by virusesูู
ุงู ุจุนุถ ุงูููุฑูุณุงุช virus |
|
|
| 107 |
| 00:09:33,330 --> 00:09:39,570 |
| induced tumor ุจูุณู
ููู
oncogenic viruses ููุฐู ุจุชุฃุฏู |
|
|
| 108 |
| 00:09:39,570 --> 00:09:44,910 |
| ุงูู ุทุจุนุง ุงุธูุฑุช cross reactivity among tumors |
|
|
| 109 |
| 00:09:44,910 --> 00:09:54,010 |
| induced by the same viruses ูุฌุฏูู ุงูุชุงูู ุจูุจููููุง |
|
|
| 110 |
| 00:09:54,010 --> 00:09:59,440 |
| ุงููุงุน tumor antigenุฒู ู
ุง ุงูุชูุง ุดุงูููู ูู embryonic |
|
|
| 111 |
| 00:09:59,440 --> 00:10:04,000 |
| ูููุง ุชุธูุฑ ุงูุงูููููุชุงู ุงูุชูุฌูู ุฒู ุงู melanoma |
|
|
| 112 |
| 00:10:04,000 --> 00:10:11,960 |
| associated gene ุงููู ูู ุฑูู
ูุงุญุฏ ูุงุชููู ุฒู ุงู |
|
|
| 113 |
| 00:10:11,960 --> 00:10:14,820 |
| carcinogenic embryonic antigen ุฒู ุงู alpha |
|
|
| 114 |
| 00:10:14,820 --> 00:10:20,730 |
| -phytoprotein ูููุง ุนุจุงุฑุฉ ุนูุงููู ูู ุงูุชูุฌูุงุช ุจุชุธูุฑ |
|
|
| 115 |
| 00:10:20,730 --> 00:10:25,290 |
| ุนูู overexpressed ุงูู
ูุฑูุถ ุงููุง ุจุชุธูุฑ ุนูู ุงู |
|
|
| 116 |
| 00:10:25,290 --> 00:10:27,930 |
| embryonic life ููููุง ุจุชุธูุฑ ุนูู ุงู tumor cell |
|
|
| 117 |
| 00:10:27,930 --> 00:10:35,270 |
| differentiation ุฒู prostate specific antigen ู |
|
|
| 118 |
| 00:10:35,270 --> 00:10:41,830 |
| ุงูุชูุฑูููุฒูู ู ุงู human epidermal growth factor |
|
|
| 119 |
| 00:10:41,830 --> 00:10:47,710 |
| ู
ุงุดู ู ูุจุนุฏ ุงู antigenุงุช ุฒู ุงู alwaysููุงู ุงูู |
|
|
| 120 |
| 00:10:47,710 --> 00:10:50,290 |
| Clonal Amplification ูููุงู ุงูู Point Immutationุ |
|
|
| 121 |
| 00:10:50,290 --> 00:10:54,550 |
| ุชุชุฑูุฏูุง ูููู
ูุงุญุฏ ู ูุงุญุฏ Normal Cellular Gene |
|
|
| 122 |
| 00:10:54,550 --> 00:11:00,290 |
| Products Expressed During Embryogenesis ูุฐุง ุฃูู |
|
|
| 123 |
| 00:11:00,290 --> 00:11:03,710 |
| ูุงุญุฏ ุงููู ูููุง ุงููู ูู ุงูู Oncofetal Antigen ุฒู |
|
|
| 124 |
| 00:11:03,710 --> 00:11:06,830 |
| ุงูู Melanoma Associated Antigen |
|
|
| 125 |
| 00:11:10,100 --> 00:11:15,100 |
| ู ุทุจุนุง ูุฐู ุนุจุงุฑุฉ ุนู ุงูุชุฌูุงุช ู
ู
ูู ูุดุชุบููุง ูุณุชุฎุฏู
ูุง |
|
|
| 126 |
| 00:11:15,100 --> 00:11:19,820 |
| ู vaccine ูุฃูู their expression is shared ูุนูู |
|
|
| 127 |
| 00:11:19,820 --> 00:11:28,060 |
| ุจุชุดุชุฑู ูู ุงูู
ููุงููู
ุฉ ุจูุฌูุฏ ูุฐู ุงูุงูุชุฌูุงุช ูุงุญูุง |
|
|
| 128 |
| 00:11:28,060 --> 00:11:31,920 |
| ุนุดุงู ูุดุชุบู ุฌูุงุฒ ุงูู
ูุงูุฑุฉ ู
ู
ูู ูุงุฎุฏูุง ู ุทุจุนุง ูุญูููุง |
|
|
| 129 |
| 00:11:31,920 --> 00:11:37,720 |
| ูุงูุชุฌูุงุช ุจุงูุชุงูู ุจุนุฏ ุทุจุนุง ู
ุง ูุนู
ููุง |
|
|
| 130 |
| 00:11:38,900 --> 00:11:43,320 |
| Inactivation ูุจุงูุชุงูู ุจูุดุฑ ุฌูุงุฒ ุงูู
ูุงุน ู
ู ุฎูุงูู |
|
|
| 131 |
| 00:11:43,320 --> 00:11:48,860 |
| Carcinogenic Carcino embryonic antigen CEA ุทุจุนุง |
|
|
| 132 |
| 00:11:48,860 --> 00:11:54,420 |
| ูุฌุฏูู ูุนูู ูุฐุง ุนุจุงุฑุฉ ุนู protein ุบุงูุจุง found in |
|
|
| 133 |
| 00:11:54,420 --> 00:12:00,800 |
| serum of patient with cancer of GIT ุฒู ุงู colon |
|
|
| 134 |
| 00:12:00,800 --> 00:12:10,650 |
| cancerูุฒูุงุฏุฉ ุงู level of CAA ูุฌุฏููุง ูู ุงูุฃู
ุฑุงุถ |
|
|
| 135 |
| 00:12:10,650 --> 00:12:14,630 |
| ุฃุฎุฑู ุบูุฑ ุงููู ูู ุงู colon cancer ุงููู ูู non |
|
|
| 136 |
| 00:12:14,630 --> 00:12:18,970 |
| specific or non neoplastic diseases ุฒู ุงู |
|
|
| 137 |
| 00:12:18,970 --> 00:12:24,190 |
| ulcerative colitis ู ุงู pancreatitis ุงููุงุณ ุฏููุฉ |
|
|
| 138 |
| 00:12:24,190 --> 00:12:29,750 |
| they don't have cancer ูุจุงูุชุงูู this test is non |
|
|
| 139 |
| 00:12:29,750 --> 00:12:36,000 |
| specificุฃููุง ููุชู ุจุฑูุชูู ูุฐุง normally present at |
|
|
| 140 |
| 00:12:36,000 --> 00:12:40,580 |
| high concentration ูู ุงูู fetal maternal serum ู |
|
|
| 141 |
| 00:12:40,580 --> 00:12:47,220 |
| it's absent ูู ุงู normal adult individual ูููู |
|
|
| 142 |
| 00:12:47,220 --> 00:12:53,340 |
| ู
ูุฌูุฏ ูู ุงููุงุณ ุงููู ุนูุฏูู
hepatoma and testicular |
|
|
| 143 |
| 00:12:53,340 --> 00:12:56,340 |
| teratocarcinoma |
|
|
| 144 |
| 00:12:59,290 --> 00:13:04,150 |
| ุงูุซุงูู ูู ุงูู Mutant Cellular Gene Product ูุงุชุฌ ุนู |
|
|
| 145 |
| 00:13:04,150 --> 00:13:09,370 |
| ู
ููุชูุดู ุฌูู ุตุงุฑ ูู ู
ููุชูุดู ููู ุฃู
ุซูุฉ ูุซูุฑุฉ ุนูู ุฐูู |
|
|
| 146 |
| 00:13:09,370 --> 00:13:15,110 |
| ู
ููุง ูู ุงููCML ุงูุชุงุฑูุฒูู ูุงูููุฒ activity ุจุชุฒูุฏ |
|
|
| 147 |
| 00:13:15,110 --> 00:13:20,510 |
| ูุจุงูุชุงูู ุจูุตูุฑ ููู ุงููู ูู uncontrolled cellular |
|
|
| 148 |
| 00:13:20,510 --> 00:13:25,650 |
| proliferation ููู ุงุณุชุฎุฏู
ูุง inhibitor ููุฌูู ุชุจุน ุงู |
|
|
| 149 |
| 00:13:25,650 --> 00:13:33,490 |
| PCR APLุงูุฌูู ุงููุงูู
ุฑููู ุงููู ูุชูููู ูู ุงููCML ุฃู |
|
|
| 150 |
| 00:13:33,490 --> 00:13:39,150 |
| ู
ุง ูุณู
ู ุจุงููููุงุฏููููุง ูุฑูู
ุงุฒูู ุงุชุดูู |
|
|
| 151 |
| 00:13:39,150 --> 00:13:43,270 |
| ุงู promise for inducing a complete hematological |
|
|
| 152 |
| 00:13:43,270 --> 00:13:49,150 |
| response ูู ูู ูุฌุงุญ ุชู
ุจุงุณุชุฎุฏุงู
ุงููinhibitor ูู |
|
|
| 153 |
| 00:13:49,150 --> 00:13:57,770 |
| ุนู
ููุฉ ูุจุญ ุฌู
ุงุญ ุงููู ูู ุงููCML diseaseุทุจุนุง ู ุงูููู
|
|
|
| 154 |
| 00:13:57,770 --> 00:14:03,750 |
| ุจูุนุชุจุฑููุง targeting therapy ุงูููู
ูุนูู ุฃุธูุฑ ูุฌุงุญุงุช |
|
|
| 155 |
| 00:14:03,750 --> 00:14:08,910 |
| ูุซูุฑุฉ ู ู
ุฑุถู ุณูุฃู
ุงู ุงุณุชุบููุง ุบุงูุจุง ุนู ุงู |
|
|
| 156 |
| 00:14:08,910 --> 00:14:13,930 |
| chemotherapy ุงูู
ุซุงู |
|
|
| 157 |
| 00:14:13,930 --> 00:14:19,610 |
| ุงูุขุฎุฑ ุนู mutant cellular gene ูู ุงู mutation ุงููู |
|
|
| 158 |
| 00:14:19,610 --> 00:14:25,050 |
| ุจุชุณูุฑ ูู ุงู P53 protein ุทุจุนุง ุงู P53 mutation |
|
|
| 159 |
| 00:14:29,510 --> 00:14:35,210 |
| ุจุชุธูุฑ ุจุชุธูุฑ ุงู it changes in p53 ูุนูู ุงููุชูุฌุฉ |
|
|
| 160 |
| 00:14:35,210 --> 00:14:42,770 |
| changes in p53 ู ุงู protein ุงููู ุจูุชูููุบุงูุจุง |
|
|
| 161 |
| 00:14:42,770 --> 00:14:47,170 |
| ุจูุดุชุบู as a suppressor of cellular growth ูุฐุง ูู |
|
|
| 162 |
| 00:14:47,170 --> 00:14:55,510 |
| ุงููุถุน ุงูุทุจูุนู ุงู ุงู P53 code for protein ุจูุนู
ู |
|
|
| 163 |
| 00:14:55,510 --> 00:15:03,870 |
| stopping ูู ash ูู cell cycle at certain ash stage |
|
|
| 164 |
| 00:15:03,870 --> 00:15:08,650 |
| ููู
ูุตูุฑ ููู ุฎูู ุจููููุงูููู
ูุตูุฑ ููู ู
ููุชูุดู ุจูุทูุน |
|
|
| 165 |
| 00:15:08,650 --> 00:15:12,730 |
| ููุง ุจุฑูุชูู ุฃุตูุง ููู ู
ููุชูุดู ุงููู ู
ู
ูู ูุนู
ู ูุดุชุบู |
|
|
| 166 |
| 00:15:12,730 --> 00:15:20,670 |
| ุงูุณุจุฑุณ ูุงูุณููุฌุฑุงุซ tumor immunity in vivo can be |
|
|
| 167 |
| 00:15:20,670 --> 00:15:25,710 |
| induced by vaccination against newton p53 peptide |
|
|
| 168 |
| 00:15:25,710 --> 00:15:35,450 |
| ูู ุงุนุทูุง ุงู p53 peptide ู
ุน ุงู I L 12 ุจูุนุชุจุฑ ูุฐุง ู |
|
|
| 169 |
| 00:15:35,450 --> 00:15:36,190 |
| vaccine |
|
|
| 170 |
| 00:15:39,970 --> 00:15:43,250 |
| ููุฌุฏูุง ุงู ุงูู T lymphocyte directed against normal |
|
|
| 171 |
| 00:15:43,250 --> 00:15:47,090 |
| B53 might preferentially destroy a tumor cell ุทุจุนุง |
|
|
| 172 |
| 00:15:47,090 --> 00:15:49,970 |
| ูุฐุง ุงูููุงู
ุจูุดูุฏ ุงู T lymphocyte ูT lymphocyte |
|
|
| 173 |
| 00:15:49,970 --> 00:15:53,610 |
| ุจุชูุงุฌู
ุงู tumor cell ูู ุจุงูุชุงูู ู
ู
ูู ูุณุชุฎุฏู
ู |
|
|
| 174 |
| 00:15:53,610 --> 00:16:01,770 |
| vaccine ูู ู ILD12 ู
ุน ุจุนุถ ู
ู ุญููู ู
ุน ุจุนุถ ุชูุงุชุฉ |
|
|
| 175 |
| 00:16:01,770 --> 00:16:05,310 |
| tumor antigen encoded by oncogen ุทุจุนุง ูููุง ุจูุนุฑู |
|
|
| 176 |
| 00:16:05,310 --> 00:16:08,830 |
| ุงู ุงู oncogen ูู ุนุจุงุฑุฉ ุนู |
|
|
| 177 |
| 00:16:13,680 --> 00:16:19,240 |
| ูุจุงูุชุงูู ุฌุงู ุจุนุฏ ู
ุง ุตุงุฑ ููู mutation ูู ุงู normal |
|
|
| 178 |
| 00:16:19,240 --> 00:16:23,020 |
| gene ู ุงู normal gene ุจูุณู
ูู proto-oncogen ุงููู |
|
|
| 179 |
| 00:16:23,020 --> 00:16:28,160 |
| ููู
ู
ุง ูุชุญูู ู proto-oncogen ู C-oncogen |
|
|
| 180 |
| 00:16:30,930 --> 00:16:35,950 |
| ุจูุชููู ุงููู ูู as a mutation ุทุจุนุง as a result of |
|
|
| 181 |
| 00:16:35,950 --> 00:16:42,990 |
| mutation ุจูุตูุฑ ููู ุงููู ูู tumor ู ุทุจุนุง ููู ุณุฌูุฉ |
|
|
| 182 |
| 00:16:42,990 --> 00:16:48,050 |
| ุญุงูุงุช ูุซูุฑุฉ ู
ู ุฎูุงู ุนูุงูุฉ ุงู tumor ุงู ุงู viruses |
|
|
| 183 |
| 00:16:48,050 --> 00:16:51,890 |
| ุจุงูุงุด ุจุงู |
|
|
| 184 |
| 00:16:55,500 --> 00:17:02,580 |
| ุฃู ูุฏุง ูู ูุธุฑูุฉ ุงูุงูููุฌูู ุชูุชุฑุญ ุฃู postulate that |
|
|
| 185 |
| 00:17:02,580 --> 00:17:06,780 |
| such proto-ankogen ููู
ุจุณูู mutation or activation |
|
|
| 186 |
| 00:17:06,780 --> 00:17:10,300 |
| display increased expression or inappropriate |
|
|
| 187 |
| 00:17:10,300 --> 00:17:14,440 |
| expression ุจุณููincreased ุงู inappropriate |
|
|
| 188 |
| 00:17:14,440 --> 00:17:18,500 |
| expression ููู mutated form of their gene a |
|
|
| 189 |
| 00:17:18,500 --> 00:17:22,480 |
| product ูุจุงูุชุงูู ุจูุณุงูู
ูุซูุฑ ูู ุชุญููู ุงูุฎูุงูุง |
|
|
| 190 |
| 00:17:22,480 --> 00:17:28,100 |
| ุงูุทุจูุนูุฉ ุงูู ุฎูุงูุง ุณุฑุทุงููุฉ ู ุงููู ุจูุชููู cancer |
|
|
| 191 |
| 00:17:28,100 --> 00:17:31,680 |
| ุทุจุนุง ุนู
ููุฉ ุงู mutation ุจุชุชู
ู
ู ุฎูุงู ุงู chromosomal |
|
|
| 192 |
| 00:17:31,680 --> 00:17:34,640 |
| translocation point limitation gene amplification |
|
|
| 193 |
| 00:17:34,640 --> 00:17:43,250 |
| ู ููุฐุง ููุฐู ุญุงูุงุช ูุซูุฑุฉู
ุงุดู ุตุงุฑ ูููุง activation ูู |
|
|
| 194 |
| 00:17:43,250 --> 00:17:48,130 |
| cellular proto-oncogen in a human ุฃู CMEC ุตุงุฑ ูู |
|
|
| 195 |
| 00:17:48,130 --> 00:17:56,170 |
| Genetic Rearrangement ู ุชุบูุฑุช ุตุงุฑ ููู |
|
|
| 196 |
| 00:17:56,170 --> 00:17:59,410 |
| Translocation ู
ุง ุจูู ููู
ุฒูู
ุงุช ุชู
ุงููุฉ ู ุฃุฑุจุนุงุด ุฃู |
|
|
| 197 |
| 00:17:59,410 --> 00:18:02,190 |
| ุชู
ุงููุฉ ู ุงุชููู ุงู ุชู
ุงููุฉ ู ุงุชููู ู ุนุดุฑูู ู ุนู
ููุง |
|
|
| 198 |
| 00:18:02,190 --> 00:18:08,860 |
| ุญุงุฌุฉ ุจูุณู
ููุง Perkins lymphomaCAPL ุฃูุถูุง ุตุฑูู |
|
|
| 199 |
| 00:18:08,860 --> 00:18:12,920 |
| Genetic Transformation ุฃู Rearrangement ู
ู ุฎูุงู |
|
|
| 200 |
| 00:18:12,920 --> 00:18:17,940 |
| Translocation ู
ุง ุจูู ูุฑูู
ุฒูู
9 ู22 ูุนู
ู CML ููุฐุง |
|
|
| 201 |
| 00:18:17,940 --> 00:18:24,800 |
| CH ุฑุงุณ CK ุฑุงุณ ู
ุฌู
ูุนุฉ ุงูุฑุงุณ ู ุงูุงูู
ู ุจุฑุถู ูููู
|
|
|
| 202 |
| 00:18:24,800 --> 00:18:30,000 |
| ุจูููููุง different types of tumor ู
ุซููุง |
|
|
| 203 |
| 00:18:30,000 --> 00:18:35,080 |
| ุงูุจุฑูุชูุงูููุฌูููุฐู ูู ููู
ู
ุง ุตุงุฑ ูู activation ูู C |
|
|
| 204 |
| 00:18:35,080 --> 00:18:43,020 |
| -Myc C-A-B-L C-K ููุฑูุฒ ุงู
ุชุฒูุณุช ุฌููุฒ are associated |
|
|
| 205 |
| 00:18:43,020 --> 00:18:47,680 |
| with Perkins lymphomasium ุงูุงููุงูููู ุงูุฑููููู |
|
|
| 206 |
| 00:18:47,680 --> 00:18:55,700 |
| ูุงุฑุณูููู
ุง ุจุงูุชุฑุชูุจ ุงูุฏุฑุงุณุงุช ุนูู ุงูุญููุงู ุงูุถุง ุงุธูุฑุช |
|
|
| 207 |
| 00:18:55,700 --> 00:19:04,150 |
| ุงู ุงู ูู ุนูุงูุฉ ู
ุจุงุดุฑุฉ ู
ุง ุจููุงูุงูููุฌูููู ููุฑูุณ ูู
ุง |
|
|
| 208 |
| 00:19:04,150 --> 00:19:11,090 |
| ุจูู cross reactivity ูุทุจุนุง ุงู
ุฑ ุทุจูุนู ุฌุฏุง ูุงู ุงู |
|
|
| 209 |
| 00:19:11,090 --> 00:19:17,710 |
| virus ุงูุงูููุฌูููู ููุฑูุณ ูุนูู ุจูุนู
ู expression of |
|
|
| 210 |
| 00:19:17,710 --> 00:19:24,190 |
| ุงู antigenุงุชู ุนูู ุงู tumor cell ุจุบุถ ุงููุธุฑ ุนูู ู
ููุน |
|
|
| 211 |
| 00:19:24,190 --> 00:19:28,830 |
| ุงูุฎูุงูุง ุงููู ุตุงุฑ ุงููู ููุง tumor ุงู ููุน ุงู animal |
|
|
| 212 |
| 00:19:28,830 --> 00:19:35,240 |
| speciesู ุฒู ู
ุง ูููุงููู
ูู ุฏูุงุฆู ุงู ูู ุณุฌูุฉ ุญุงูุงุช |
|
|
| 213 |
| 00:19:35,240 --> 00:19:41,600 |
| ูุซูุฑุฉ ู
ุซุจุชุฉ ุนูู ุนูุงูุฉ ุงููู ูู ุงู viruses ุจุงู tumor |
|
|
| 214 |
| 00:19:41,600 --> 00:19:47,200 |
| ุฒู ุงู Epstein-Barr Virus ุจูุนู
ู ุงููู ูู ุงู ุงู human |
|
|
| 215 |
| 00:19:47,200 --> 00:19:51,520 |
| T cell leukemia virus ู ุงู human papilloma virus |
|
|
| 216 |
| 00:19:51,520 --> 00:19:54,820 |
| ุงูุฃููุงูู ุจูุนู
ู Perkins ูุงูุชุงูู ุจูุนู
ู leukemia |
|
|
| 217 |
| 00:19:54,820 --> 00:19:57,840 |
| ูุงูุชุงูุช ุจูุนู
ู cervical tumor |
|
|
| 218 |
| 00:20:01,280 --> 00:20:06,980 |
| ู
ุง ูู ุงูุนูุงู
ู ุงูุชู ุชุคุซุฑ ูู ุงู incidence of cancer |
|
|
| 219 |
| 00:20:06,980 --> 00:20:15,520 |
| ูุงููุง ูู ู
ุตุทูุญ ุงุณู
ู ุงู immune ุงู immune |
|
|
| 220 |
| 00:20:15,520 --> 00:20:20,270 |
| surveillance ูุงูู
ุตุทูุญ ูุฐุง ูุนููุฅูู ููู |
|
|
| 221 |
| 00:20:20,270 --> 00:20:22,990 |
| immunological resistance against the development |
|
|
| 222 |
| 00:20:22,990 --> 00:20:32,150 |
| of cancer ุงูุฌุณู
ูุชุตุฏู ุฅูู ุงู tumor ู
ู ุฎูุงู ุฌูุงุฒ |
|
|
| 223 |
| 00:20:32,150 --> 00:20:37,490 |
| ุงูู
ุงูุนุฉ ูู
ู ุงููุงุณ ุงููู ู
ุง ุนูุฏูู
ุด ู
ุงูุนุฉ ุนูุฏูู
|
|
|
| 224 |
| 00:20:37,490 --> 00:20:40,590 |
| immunodeficiency disease usually are susceptible |
|
|
| 225 |
| 00:20:40,590 --> 00:20:45,070 |
| to viral infection and certain malignant neoplasm |
|
|
| 226 |
| 00:20:52,140 --> 00:20:59,480 |
| ุทุจุนุง ุงู tumor cell ุงููู ุจุชุชููู ุฎูุงู virus are |
|
|
| 227 |
| 00:20:59,480 --> 00:21:04,420 |
| sensitive to immunologic destruction ูู
ุน ุฐูู ุงู |
|
|
| 228 |
| 00:21:04,420 --> 00:21:07,400 |
| natural development of immunological response |
|
|
| 229 |
| 00:21:07,400 --> 00:21:10,600 |
| usually fail to prevent cancer from developing |
|
|
| 230 |
| 00:21:10,600 --> 00:21:16,060 |
| ูุนูู ุตุญูุญ ุฌูุงุฒ ุงูู
ูุนุจ ุจูุดุชุบู ููู ูู
ุน ุฐูู ุงูุณุฑุทุงู |
|
|
| 231 |
| 00:21:16,060 --> 00:21:25,020 |
| ุงู ุงู tumor cell ุจุชูุฌุญ ููููู ุฅุฏูุง ุชูู
ู ูุชุชุทูุฑ ูุนูู |
|
|
| 232 |
| 00:21:25,020 --> 00:21:31,320 |
| ุจูุฃู
ู ูู ุงูู
ุณุชูุจู ุฃู ูููู ููู good |
|
|
| 233 |
| 00:21:31,320 --> 00:21:36,720 |
| response example by vaccination with tumor antigen |
|
|
| 234 |
| 00:21:36,720 --> 00:21:41,280 |
| that will serve as viable option for prevention or |
|
|
| 235 |
| 00:21:41,280 --> 00:21:47,490 |
| treatment of cancer in the futureEffect of |
|
|
| 236 |
| 00:21:47,490 --> 00:21:50,770 |
| Mechanism in Tumor Immunology ู
ุง ูู ุงูู
ููุงููุฒู
ุงุช |
|
|
| 237 |
| 00:21:50,770 --> 00:21:55,690 |
| ูุฌุฏูุง ุงูู both Adaptive ู Innate Immune Response |
|
|
| 238 |
| 00:21:55,690 --> 00:22:01,970 |
| ุจูุนุจูุง ุฏูุฑ ูุจูุฑ ู ูู ุงูุนูุงูุฉ ู
ุง ุจูู ุงู host ู ุงู |
|
|
| 239 |
| 00:22:01,970 --> 00:22:08,290 |
| tuner Immune Effect of Mechanism ูุฌุฏุช ูุฌุฏููุง ุงู it |
|
|
| 240 |
| 00:22:08,290 --> 00:22:13,760 |
| can destroy tumor cell in vitroุจุงูุชุฌุฑุจุฉ ุชุชู
ุซู ูู |
|
|
| 241 |
| 00:22:13,760 --> 00:22:18,280 |
| ุงูู Antibody ูู ุงูู D-cellุ ุงูู NK-cellุ ุงูู Lact |
|
|
| 242 |
| 00:22:18,280 --> 00:22:22,240 |
| -cellุ ุงูู Macrophaginุ ุงููCytokine ูููุง ุฃุจุงุฑุน ุนู |
|
|
| 243 |
| 00:22:22,240 --> 00:22:27,660 |
| ู
ููุงููุฒู
ุงุช ุฃุซุจุชุช in vitro ุจุฅููุง ุจุชุฏู
ุฑ ุงูุฎูุงูุง |
|
|
| 244 |
| 00:22:27,660 --> 00:22:33,860 |
| ุงูุณุฑุทุงููุฉ ููู ุงูู Antibody ู ุงูู B-cell ุนูู ุณุจูู |
|
|
| 245 |
| 00:22:33,860 --> 00:22:36,820 |
| ุงูู
ุซุงู ูู ูุฌูุฏ ููู
ุจูู ุจุชููู Antibody ูู ูุฌูุฏ |
|
|
| 246 |
| 00:22:36,820 --> 00:22:43,040 |
| ููู
ุจูู ู
ูุชุฌุงุช ุฃู Optionizationุงูุงู ู
ููุงููุฒู
ู
ูููู
|
|
|
| 247 |
| 00:22:43,040 --> 00:22:46,980 |
| ุจุดูู ูุงู
ุชุณู |
|
|
| 248 |
| 00:22:46,980 --> 00:22:49,460 |
| ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู |
|
|
| 249 |
| 00:22:49,460 --> 00:22:53,260 |
| ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู |
|
|
| 250 |
| 00:22:53,260 --> 00:22:58,100 |
| ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู |
|
|
| 251 |
| 00:22:58,100 --> 00:23:01,720 |
| ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู |
|
|
| 252 |
| 00:23:01,720 --> 00:23:05,360 |
| ุชุณู |
|
|
| 253 |
| 00:23:07,310 --> 00:23:14,930 |
| ููุฌุฏููุง ูุซูุฑ ูููุฉ ุนูู ุงูุฎูุงูุง ุงูู dispersed ุงููู |
|
|
| 254 |
| 00:23:14,930 --> 00:23:21,030 |
| ูู ุงูู
ููุตูุฉ ุนูู ุงู cell suspension ููุฌุฏูุง ูุนุงููุชูุง |
|
|
| 255 |
| 00:23:21,030 --> 00:23:26,890 |
| ุงูุชุฑ ุจูุซูุฑ ุนูู ูุฐู ุงูุฎูุงูุง ุงูู
ููุตูุฉ ุงูุชุฑ ู
ู ุงู |
|
|
| 256 |
| 00:23:26,890 --> 00:23:31,250 |
| solid tumor ุงููู ูู ุจูููู ู
ุชู
ุงุณู ููุดุ ูุฃู ุฌูุงุฒ |
|
|
| 257 |
| 00:23:31,250 --> 00:23:33,850 |
| ุงูู
ูุงุน ูุณุชุทูุน ุงู ูุตู ุงูู ูุฐู ุงูุฎูุงูุง |
|
|
| 258 |
| 00:23:37,530 --> 00:23:43,770 |
| ู
ู ุงูู Solid Tumour Cells ูุดูู ุฃูู ู
ููุงููุฒู
ุงููู |
|
|
| 259 |
| 00:23:43,770 --> 00:23:49,890 |
| ูู PCR Response ูู Tumour ูุฌุฏูุง ุฃู IgPo, IgM ู IgG |
|
|
| 260 |
| 00:23:49,890 --> 00:23:55,690 |
| Antibody ูุฌุฏููุง in vitro can kill or destroy the |
|
|
| 261 |
| 00:23:55,690 --> 00:24:00,450 |
| tumour cell ุทุจุนุง ูู ูุฌูุฏ ุงู complement ุทุจุนุง ูุฐุง |
|
|
| 262 |
| 00:24:00,450 --> 00:24:07,370 |
| ุงูููุงู
ุฃุซุจุชูุงู ุจุงูุชุฌุฑุจุฉ in vitroุงูุฏุฑุงุณุงุช ุนูู |
|
|
| 263 |
| 00:24:07,370 --> 00:24:15,830 |
| ุงูู
ุงูุณ ุงูุถุง ุงุซุจุชุช Indicate ุจุชุคุดุฑ ุงู ุจุชุฏู ุนูู ุงู ุงู |
|
|
| 264 |
| 00:24:15,830 --> 00:24:19,350 |
| Antitumor Antibody are effective in destroying |
|
|
| 265 |
| 00:24:19,350 --> 00:24:25,250 |
| some leukemia and lymphoma ูุทุจุนุง ุจุชููู ู
ู ุงู |
|
|
| 266 |
| 00:24:25,250 --> 00:24:31,710 |
| metastasis in several other tumors system ุชูุณูุด |
|
|
| 267 |
| 00:24:31,710 --> 00:24:37,780 |
| ุงูู ุงุญูุง ููุญูู ุนููุชุฌุงุฑุจ ุญุฏุซุช in vitro ูููุณ in vivo |
|
|
| 268 |
| 00:24:37,780 --> 00:24:43,860 |
| ุงุฎุฑ ุญุฏุซ ุทุจุนุง ุงุซุจุชุช ุงู ูุฐู ุงูุงูุชูุจุงุฏู ูุง ุชุฃุซูุฑ ููุง |
|
|
| 269 |
| 00:24:43,860 --> 00:24:50,500 |
| ููุง ุจุชุจุชู ุฎูุงูุง ุณุฑุทุงููุฉ ู
ุงุดู ุงุฐุง ูุงู ุงู tumor in |
|
|
| 270 |
| 00:24:50,500 --> 00:24:55,820 |
| solid form ููู
ู
ุง ูููู ุงู tumor in solid formุจูุงุฒู
|
|
|
| 271 |
| 00:24:55,820 --> 00:24:58,760 |
| ุชุงูู destruction of tumor cell by opsonization of |
|
|
| 272 |
| 00:24:58,760 --> 00:25:02,320 |
| phagocytosis ูููุง ุจูุนุฑู ุฃูู ุงูุฎููุฉ ุงูุบุฑูุจุฉ ุจูู |
|
|
| 273 |
| 00:25:02,320 --> 00:25:05,960 |
| ุชููู ููุง antibody ู ุจูุนุฏ ุนูู ุณุทุญ ุงูุฎูุงูุง ู
ุฑุงุช ู |
|
|
| 274 |
| 00:25:05,960 --> 00:25:11,240 |
| ุจูุตูุฑ ููู ู ุจูุนู
ู opsonization ููุฐู ุงูุฎููุฉ ุทุจุนุง |
|
|
| 275 |
| 00:25:11,240 --> 00:25:15,240 |
| ุชุชุนุฑู ุนูููุง ุงู phagocytic cell ู ุจุชุฎูุตูุง ู
ููุงIn |
|
|
| 276 |
| 00:25:15,240 --> 00:25:23,980 |
| vitro destruction of tumor cell ุจูุงุณุทุฉ Trigocytic |
|
|
| 277 |
| 00:25:23,980 --> 00:25:28,780 |
| cell ุฃุตูุง ูุชู |
|
|
| 278 |
| 00:25:28,780 --> 00:25:32,900 |
| ุฃู ุนู
ู destruction ูู tumor cell ูู ูุฌูุฏ ุงู ant |
|
|
| 279 |
| 00:25:32,900 --> 00:25:39,360 |
| tumor ุงููู ูู immune serum and complement ู
ููุงููุฒู
|
|
|
| 280 |
| 00:25:39,360 --> 00:25:43,220 |
| ุชุงูุช Antibody-mediated loss of adhesion properties |
|
|
| 281 |
| 00:25:43,220 --> 00:25:52,080 |
| of tumor cellุงูู Adhesion Molecule ูุงุฒู
ุชุชุญูู |
|
|
| 282 |
| 00:25:52,080 --> 00:25:56,540 |
| ุนุดุงู ูุตูุฑ ููู ู
ุชุงุณุชุงุณูุณ |
|
|
| 283 |
| 00:25:56,540 --> 00:26:01,300 |
| ู
ุชุงุณุชุงุณูุณ ุงูุชููุฉ ู
ุฎุชููุฉ ุนู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู |
|
|
| 284 |
| 00:26:01,300 --> 00:26:06,240 |
| ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู |
|
|
| 285 |
| 00:26:10,100 --> 00:26:15,140 |
| ุนุดุงู ุชุฑุชุจุท ุจุฎูุงูุง ุงู ุจุงูุณุฌุฉ ุงุฎุฑู ู
ูุฌูุฏุฉ ูู ุงู
ุงูู |
|
|
| 286 |
| 00:26:15,140 --> 00:26:19,300 |
| ุงุฎุฑู ูุจุงูุชุงูู ุจูุญุตู ููู metastasis ุงู antibody |
|
|
| 287 |
| 00:26:19,300 --> 00:26:24,220 |
| ุงูู
ูุฌูุฉ ุถุฏ ูุฐู ุงูู tumor cell surfaces can |
|
|
| 288 |
| 00:26:24,220 --> 00:26:28,080 |
| interfere with the adhesive properties ููุฐุง ุงูููุงู
|
|
|
| 289 |
| 00:26:28,080 --> 00:26:33,200 |
| ุงูุถุง done in vitro cell mediated responses |
|
|
| 290 |
| 00:26:33,200 --> 00:26:38,100 |
| destruction by cytotoxic T lymphocytes ุงูุถุง |
|
|
| 291 |
| 00:26:38,100 --> 00:26:44,150 |
| ุงุซุจุชูุงูุง in vitroูู ู
ุณุคููุฉ ุนู ูุฐู ุงูุฎูุงูุง ูู
ุณุคููุฉ |
|
|
| 292 |
| 00:26:44,150 --> 00:26:52,830 |
| ุนู ุฅุฏุงุฑุฉ ุชู
ุฑ ุณู ุจูุฑูุง ูู ุงููุงูุนุทุจุนุง ุงูู Antibody |
|
|
| 293 |
| 00:26:52,830 --> 00:26:55,890 |
| Dependent Cell Mediated Cytotoxicity ุฏู ุนุจุงุฑุฉ ุนู |
|
|
| 294 |
| 00:26:55,890 --> 00:27:01,870 |
| ู
ููุงููุฒู
ุจุชู
ู ุฎูุงู ุงุฑุชุจุงุท ุงู .. ุงู .. ุงู .. ุงู .. |
|
|
| 295 |
| 00:27:01,870 --> 00:27:06,090 |
| Phagocytic Cell ุจุงู Fc Portion of Antibody ุงููู |
|
|
| 296 |
| 00:27:06,090 --> 00:27:09,670 |
| ุฌุงุนุฏ ุนูู ุณุทุญ ุงูุฎููุฉ ุงูุณุฑุทุงููุฉุ ุจุงูุชุงูู ุจูุตูุฑ ูู |
|
|
| 297 |
| 00:27:09,670 --> 00:27:14,510 |
| cell to cell contact ู ุจูุตูุฑ ูู releasing ู ุงู |
|
|
| 298 |
| 00:27:14,510 --> 00:27:20,050 |
| substance which can kill the tumor cellุงุณุชุฑูุดู of |
|
|
| 299 |
| 00:27:20,050 --> 00:27:31,790 |
| tumors by NK or NKT or ูุฃูุณู ุงูุชูุงุชุฉ ู
ุงุดู ูุง ุนูุงูุฉ |
|
|
| 300 |
| 00:27:31,790 --> 00:27:35,650 |
| ุทุจุนุง ููุง ุจูุนุฑู ุงูู ุฎูุงุต ุงู ุงูุงููุณู ุชุชุญุณุณ ุงููู ูู |
|
|
| 301 |
| 00:27:38,140 --> 00:27:42,000 |
| ู
ููููููู ุนูู ุณุทุญ ุงูุฎูุงูุง ุชููู
ุฑ ุณูู ุบุงูุจุง ุชุนู
ู |
|
|
| 302 |
| 00:27:42,000 --> 00:27:46,620 |
| shading ุชุนู
ู masking ู ุงููู ูู ุงู MSC ู
ููููููู |
|
|
| 303 |
| 00:27:46,620 --> 00:27:52,520 |
| ูุจุงูุชุงูู ุชุชุนุฑู ุนูููุง ุงููู ูู ุงูุงููุณู ุฃูุถุง ุงูุงููุณู |
|
|
| 304 |
| 00:27:52,520 --> 00:27:56,960 |
| have receptor ูู FC portion of IGG ูุจุงูุชุงูู ู
ู |
|
|
| 305 |
| 00:27:56,960 --> 00:28:04,500 |
| ุฎูุงู ADCC ู
ู
ูู ุชุชุฎูุต ู
ู ุงู tumor cellุจู
ุฌุฑุฏ ู
ุง |
|
|
| 306 |
| 00:28:04,500 --> 00:28:07,680 |
| ุชุฑุชุจุท ุจุชูุฑุฒ ุงู tumor ูุฅู ูู cell tumor necrosis |
|
|
| 307 |
| 00:28:07,680 --> 00:28:13,120 |
| factor ฮฑ ู ุงููู ุจูุนู
ููู
ูุฑุฌู tumor necrosis ุงู lag |
|
|
| 308 |
| 00:28:13,120 --> 00:28:18,820 |
| ุฃูุถุง ูู ุนุจุงุฑุฉ ุนู tumor specific killer cells ู |
|
|
| 309 |
| 00:28:18,820 --> 00:28:22,660 |
| ู
ู
ูู ูุณุชูุจุทูุง ุฃู ูุงุฎุฏูุง ู
ู ุจุนุถ ุงูู
ุฑุถู ุงููู ุนูุฏูู
|
|
|
| 310 |
| 00:28:22,660 --> 00:28:29,400 |
| tumorุจูู
ููุง ุจุฑุง ูู ูุฌูุฏ IL-2 ููุฑุฌุนูุง ุชุงูู ููู
ุฑูุถ |
|
|
| 311 |
| 00:28:29,400 --> 00:28:36,920 |
| ููุณู ูุฏููุฉ ุจูุดุทู ุงููู ูู ุงูู mechanism ุงููู ุจูุญูู |
|
|
| 312 |
| 00:28:36,920 --> 00:28:40,580 |
| ุนูู ุณูุงุก ูุงู ADCC ุงู Direct Killing By Ankyl Cell |
|
|
| 313 |
| 00:28:40,580 --> 00:28:43,600 |
| Destruction |
|
|
| 314 |
| 00:28:43,600 --> 00:28:46,300 |
| of tumor cell by activated macrophage and |
|
|
| 315 |
| 00:28:46,300 --> 00:28:50,800 |
| neutrophil ุทุจุนุง ูููุง ุจูุนุฑู ุงู ุงู macrophage ุจุชุชูุดุท |
|
|
| 316 |
| 00:28:51,320 --> 00:28:57,540 |
| by releasing gamma interferon ุงูุชุดุชุช ู
ู ุฎูุงู TCD4 |
|
|
| 317 |
| 00:28:57,540 --> 00:29:08,620 |
| lymphocytes ูุทุจุนุง ุงู gamma interferon ูู tumor |
|
|
| 318 |
| 00:29:08,620 --> 00:29:15,280 |
| specific ุจูุณุชุฎุฏู
|
|
|
| 319 |
| 00:29:15,280 --> 00:29:16,480 |
| ู cytotoxic |
|
|
| 320 |
| 00:29:20,430 --> 00:29:26,630 |
| Cytokine against tumor cell ุงูุถุง ุจุฅุทูุงู ูุงุฒูุฒุงูู
|
|
|
| 321 |
| 00:29:26,630 --> 00:29:30,730 |
| ูููุฑูุณ ูุงูุชูุฑู ุงููุง ุจููุชููุง tumor cell |
|
|
| 322 |
| 00:29:35,370 --> 00:29:38,730 |
| ุฃู
ุง ุชุนู
ู Inhibition ุฃู ุชุนู
ู Growth ููPremarignant |
|
|
| 323 |
| 00:29:38,730 --> 00:29:44,050 |
| ูTumorignant Cell ุทุจุนุงู ูุนุฑู ุฃูู ููู Cytokine |
|
|
| 324 |
| 00:29:44,050 --> 00:29:47,650 |
| Inhibitor ูCytokine ูููู Stimulatory Transformed |
|
|
| 325 |
| 00:29:47,650 --> 00:29:51,350 |
| Growth Factor Beta ูุงุญุฏ ู
ู ุงููCytokine ุงููู ุจูุนู
ู |
|
|
| 326 |
| 00:29:51,350 --> 00:29:56,990 |
| Inhibition ูู immune response ูุจุงูุชุงูู ุจูุตูุฑ ููู |
|
|
| 327 |
| 00:29:56,990 --> 00:30:04,460 |
| promotion ูู tumor growth ูู ูุฐู ุงูุญุงูุฉ ู ุจูุงูู |
|
|
| 328 |
| 00:30:04,460 --> 00:30:08,980 |
| ุงูุฌููุฌูููู ุจู
ุนูู |
|
|
| 329 |
| 00:30:08,980 --> 00:30:16,720 |
| ุงูู ุจูุณูู ูู ุนู
ููุฉ ูู
ู ุงููุงูุณุฑ ู
ู ุฎูุงู ุงููู ูู |
|
|
| 330 |
| 00:30:16,720 --> 00:30:23,120 |
| ุชูููู ุงูุงูุฌููุฌูููุณู ุงููู ูู blood vessels to the |
|
|
| 331 |
| 00:30:23,120 --> 00:30:25,360 |
| tumor cell |
|
|
| 332 |
| 00:30:27,510 --> 00:30:32,910 |
| Tumor Microsfactory ู Interferon ุฌุนู
ุง ุฃูุถุง ููู
|
|
|
| 333 |
| 00:30:32,910 --> 00:30:37,770 |
| Anti-Tumor Effect ููุดุ ูุฃููู
ุจูุนู
ููุง Upregulation |
|
|
| 334 |
| 00:30:37,770 --> 00:30:44,190 |
| ูู MSC Class 1 ู2 ูุจุงูุชุงูู ุฌูุงุฒ ุงูู
ูุนุจ ูุชุนุฑู ุนูููู
|
|
|
| 335 |
| 00:30:44,190 --> 00:30:48,590 |
| ุจุณูููุฉ ููู
ู
ุง ูุญุตู ููู Decrease expression ููMSC |
|
|
| 336 |
| 00:30:48,590 --> 00:30:54,770 |
| Determinants ุนูู ุณุทุญ ุงู tumor cell ุจูููู ูุณููุฉ ู
ู |
|
|
| 337 |
| 00:30:54,770 --> 00:30:59,450 |
| ูุณุงุฆู ุชูุฑุจ ุงูุฎููุฉ ุงูุณุฑุทุงููุฉfrom the action of |
|
|
| 338 |
| 00:30:59,450 --> 00:31:05,450 |
| cytokine transfection |
|
|
| 339 |
| 00:31:05,450 --> 00:31:12,470 |
| of tumor cell with genes coding for cytokine ุฒู IL |
|
|
| 340 |
| 00:31:12,470 --> 00:31:21,430 |
| -117 ููุงู
ุงูุชุฑููุฑูู ู
ุงุดู ู ุจุนุฏ ุฐูู ุฑุฌุนูู
ู
ุงุดู |
|
|
| 341 |
| 00:31:21,430 --> 00:31:22,290 |
| ููู
ุฑูุถ |
|
|
| 342 |
| 00:31:25,210 --> 00:31:32,150 |
| ุฃููู ุงู tumor-pairing mice ุฃุธูุฑุช ูุชุงุฆุฌ ุฌูุฏุฉ ูู |
|
|
| 343 |
| 00:31:32,150 --> 00:31:38,150 |
| ุงูุงูููุจุดู of growth of tumor ุทูุจุ |
|
|
| 344 |
| 00:31:38,150 --> 00:31:43,430 |
| ุฅูุด ุงู limitation of effectiveness of immune |
|
|
| 345 |
| 00:31:43,430 --> 00:31:47,090 |
| response against tumorุ ูููุง ุจูุนุฑู ุฃูู ู
ุน ูุฌูุฏ |
|
|
| 346 |
| 00:31:47,090 --> 00:31:54,710 |
| immune response ูุฃู tumor cell ุฃู tumor can growู |
|
|
| 347 |
| 00:31:54,710 --> 00:32:02,310 |
| ุจูุชุบูุจ ุนูู ุงูุฌูุงุฒ ุงูู
ูุนููุด ูุดูู ุงููุฉ there is no |
|
|
| 348 |
| 00:32:02,310 --> 00:32:05,430 |
| question ุงูู ูู ูุฌูุฏ ุงู immune response ุงู immune |
|
|
| 349 |
| 00:32:05,430 --> 00:32:13,050 |
| response ุจูููู ุดุบุงู ูู ูุฌูุฏ ุงู tumor ููู ุจุงูุฑุบู
|
|
|
| 350 |
| 00:32:13,050 --> 00:32:20,350 |
| ุฐูู ุงู tumor continue to grow ู ุทุจุนุง ุฏุฑุณูุง ุนุฏุฉ |
|
|
| 351 |
| 00:32:20,350 --> 00:32:21,330 |
| ู
ููุงููุฒู
ุงุช |
|
|
| 352 |
| 00:32:23,960 --> 00:32:35,180 |
| ุทุจุนุง ูุฐู ุจุชุชุนูู ุจุงู tumor cell ุงู ุจ tumor and host |
|
|
| 353 |
| 00:32:35,180 --> 00:32:38,380 |
| relationship |
|
|
| 354 |
| 00:32:38,380 --> 00:32:44,360 |
| ูุดูู ุงูู
ููุงููุฒู
ุงุช ุงููู ุจุชุชุนูู ุจุงู tumorูููู ุฅู ู
ู |
|
|
| 355 |
| 00:32:44,360 --> 00:32:47,540 |
| ูุงุญุฏ failure of tumor to provide suitable target |
|
|
| 356 |
| 00:32:47,540 --> 00:32:52,040 |
| ูุนูู ููู ุชุชุนุฑู ูุชุนุฑู ุนูููุง ุฌูุงุฒ ุงูู
ูุงุนุฉ ุจุฏู ูููู |
|
|
| 357 |
| 00:32:52,040 --> 00:32:56,060 |
| ููู target ุจุฏู ูููู ููู antigen ูุดูู ุงููุณุงุฆู ุงูุชู |
|
|
| 358 |
| 00:32:56,060 --> 00:33:01,640 |
| ุชุชูุฑุจ ู
ู ุฎูุงููุง ุงู tumor cell from the immune |
|
|
| 359 |
| 00:33:01,640 --> 00:33:06,020 |
| response ูููู ุฅู ู
ู ูุงุญุฏ ุชุงููุจ antigen ููุจุชู ุจุชุทูุน |
|
|
| 360 |
| 00:33:06,020 --> 00:33:10,050 |
| ูู ุงู antigenุงุช ุงููู ุนูู ุณุทุญูุง ูุจุงูุชุงูููู ุงู tumor |
|
|
| 361 |
| 00:33:10,050 --> 00:33:13,550 |
| ุงูุชูุฌูู ู
ุด ู
ูุฌูุฏุฉ ูููุจุฑู ุงุชุนุฑู ุนูููุง ุฌุฒุก ู
ููุง ูู
ุฑ |
|
|
| 362 |
| 00:33:13,550 --> 00:33:16,770 |
| ุงุชููู lack of a C class one molecule ุทุจ ู
ุง ูู ุฏู |
|
|
| 363 |
| 00:33:16,770 --> 00:33:21,970 |
| ุนุจุงุฑุฉ ุนู presenting molecule ููุงูุชูุฌูู deficient |
|
|
| 364 |
| 00:33:21,970 --> 00:33:25,510 |
| of antigen processing ุงุตูุง ู
ุงููุด ุงูุชูุฌูู ุนุดุงู |
|
|
| 365 |
| 00:33:25,510 --> 00:33:29,770 |
| ูุนู
ูู processing antigenic modulation ุจูุบูุฑ ุงูุฌูุงุฒ |
|
|
| 366 |
| 00:33:29,770 --> 00:33:36,270 |
| ุงูุฎููุฉ ุงูุณุฑุทุงููุฉ ูู ุงูุงูุชูุฌูู ุจุงุณุชู
ุฑุงุฑ ูุจุงูุชุงูู |
|
|
| 367 |
| 00:33:36,270 --> 00:33:41,000 |
| ุจูุตูุฑ ูู ุงููุุฎูู ูู ุงูุชุนุฑู ุนููู antigenic masking |
|
|
| 368 |
| 00:33:41,000 --> 00:33:46,740 |
| of the tumor ููู
ูุบุทู ุงูุงูุชุฌูู ููุฑููุง ุงูุฎููุฉ |
|
|
| 369 |
| 00:33:46,740 --> 00:33:51,420 |
| ุงูุณุฑุทุงููุฉ ุจุฑุถู ูุงุชุณุชุทูุน ุงู ุชุชุนุฑู ุนูููุง resistance |
|
|
| 370 |
| 00:33:51,420 --> 00:33:55,260 |
| of tumor cell to tumor seedal effector pathway ุจุนุฏ |
|
|
| 371 |
| 00:33:55,260 --> 00:34:01,540 |
| ุงูุฎููุฉ ุงูุณุฑุทุงููุฉ ุจุชูุงูู
any ุงููู ูู tumor seedal |
|
|
| 372 |
| 00:34:01,540 --> 00:34:02,620 |
| effector pathway |
|
|
| 373 |
| 00:34:05,230 --> 00:34:10,050 |
| ูุงูููุน ุงูุชุงูู ุงู ุงูุนุงู
ู ุงูุชุงูู failure of tumor to |
|
|
| 374 |
| 00:34:10,050 --> 00:34:18,910 |
| induce ineffective immune response ุทุจุนุง ุฒู ู
ุง |
|
|
| 375 |
| 00:34:18,910 --> 00:34:29,170 |
| ููููุง ุจุตูุฑ ููู ูุดู ูู ุงููู ูู ุชูููู ุงู immune |
|
|
| 376 |
| 00:34:29,170 --> 00:34:29,890 |
| response |
|
|
| 377 |
| 00:34:32,510 --> 00:34:36,530 |
| ูุทุจุนุง ูุฌูุฏ ุงู tumor ูุนูู ุงูู ูุงุฒู
ูุตูุฑ ููู |
|
|
| 378 |
| 00:34:36,530 --> 00:34:40,450 |
| response ุจุนุถ ุงูู
ุฑุงุช ุจููุดู ุงู tumor ูู ุชุญููู ูุฐู |
|
|
| 379 |
| 00:34:40,450 --> 00:34:43,930 |
| ุงูุธุงูุฑุฉ ุจุณุจุจ ูู ุฐูู lack of antigenic epitopes |
|
|
| 380 |
| 00:34:43,930 --> 00:34:48,770 |
| ู
ุงููุด epitopes ูู
ุฑุฉ ุงุชููู decrease MSC or tumor |
|
|
| 381 |
| 00:34:48,770 --> 00:34:52,970 |
| antigen expression ูู
ุฑุฉ ุชูุงุชุฉ ู
ุงููุด costimulatory |
|
|
| 382 |
| 00:34:52,970 --> 00:34:56,570 |
| signalูู
ุฑุฉ ุฃุฑุจุนุฉ production of inhibitory |
|
|
| 383 |
| 00:34:56,570 --> 00:35:02,390 |
| substance ูู ุจุนุถ ุงูุตูุชุฑูุงูู ุงููู ููุดูููุง ูู
ุฑุฉ ุฎู
ุณุฉ |
|
|
| 384 |
| 00:35:02,390 --> 00:35:07,230 |
| shedding of tumor antigen in the surrounding area |
|
|
| 385 |
| 00:35:07,230 --> 00:35:10,690 |
| ุงู in the blood ูุจุงูุชุงูู ุจูุตูุฑ ูู tolerance ูู |
|
|
| 386 |
| 00:35:10,690 --> 00:35:18,250 |
| antigen ูู ุงูุฌุณู
ูู
ุฑุฉ ุณุชุฉ ุงููู ูู induction of T |
|
|
| 387 |
| 00:35:18,250 --> 00:35:24,550 |
| cell signaling defect by tumor burden ู
ุงููุด cell |
|
|
| 388 |
| 00:35:24,550 --> 00:35:32,170 |
| signal ุทูุจ ูุฐุง ู
ุงูุชุนูู ุจุงู tumor ูุดูู ู
ุงูุชุนูู ุจุฅูุด |
|
|
| 389 |
| 00:35:32,170 --> 00:35:35,050 |
| ุจุงูู host |
|
|
| 390 |
| 00:35:46,230 --> 00:35:50,450 |
| failure of the host to respond to antigenic tumor |
|
|
| 391 |
| 00:35:50,450 --> 00:35:54,430 |
| ูุงููุง ุจุนุฏ ู
ุฑุงุช ุจูููู ููู neuro suppression or |
|
|
| 392 |
| 00:35:54,430 --> 00:36:01,530 |
| deficiency of the host ุจุงุดู ุจุชุดู
ู ุงุจูุชูุฒูุณ ู |
|
|
| 393 |
| 00:36:01,530 --> 00:36:05,810 |
| signaling defect of the T cell ูุงูุณุจุจ ูู ุฐูู ูุฌูุฏ |
|
|
| 394 |
| 00:36:05,810 --> 00:36:08,470 |
| ูุงุฑุณูููุฌูููู agent ูุงู ูุงู physical or chemical |
|
|
| 395 |
| 00:36:08,470 --> 00:36:15,410 |
| agent or infection or even ageุฃู ูุนูู ุงููุงุณ |
|
|
| 396 |
| 00:36:15,410 --> 00:36:19,030 |
| ุงูุงุฎุชูุงุฑูุฉ ูู
ุงู ู
ู
ููุงุด ูู
ุฑุฉ ุงุชููู deficient |
|
|
| 397 |
| 00:36:19,030 --> 00:36:22,170 |
| presentation of tumor antigen ู
ุงูู by the host |
|
|
| 398 |
| 00:36:22,170 --> 00:36:24,530 |
| antigen presenting cell ู
ุงูุฏุฑุชุด ุงู antigen |
|
|
| 399 |
| 00:36:24,530 --> 00:36:28,430 |
| presenting cell ุงููู ูู ุชุนู
ู antigen presentation |
|
|
| 400 |
| 00:36:28,430 --> 00:36:33,070 |
| ูู tumor antigen ุงููู
ุฑุฉ ุชูุงุชุฉ failure of host |
|
|
| 401 |
| 00:36:33,070 --> 00:36:37,970 |
| effector to reach tumor ุจุนุถ ุงูู
ุฑุงุช ุจูููู ุงู tumor |
|
|
| 402 |
| 00:36:37,970 --> 00:36:41,790 |
| ู
ุชุฎุจู ูู ุฃู
ุงูู ูุง ูุณุชุทูุน ุงู ุชุตู ุงูููุง ุฌูุงุฒ ุงูู
ูุน |
|
|
| 403 |
| 00:36:41,790 --> 00:36:47,640 |
| ุฒู ุงู stromer carrierู
ุฑุฉ ุฎู
ุณุฉ host failure of host |
|
|
| 404 |
| 00:36:47,640 --> 00:36:54,420 |
| to kill variant tumor cell because of dominant |
|
|
| 405 |
| 00:36:54,420 --> 00:36:58,760 |
| immunodominant antigen on parental tumor cell ุทุจุนุง |
|
|
| 406 |
| 00:36:58,760 --> 00:37:05,100 |
| ุจูููู ุงู antigen ูู ูุฐู ุงูุญุงูุฉ dominant |
|
|
| 407 |
| 00:37:05,100 --> 00:37:15,530 |
| antigen ุนูู ุงู parentalุงููู ูู tumor cell |
|
|
| 408 |
| 00:37:15,530 --> 00:37:22,610 |
| immunodiagnosis |
|
|
| 409 |
| 00:37:22,610 --> 00:37:27,750 |
| ููุด ุจุฏูุง ูุนู
ู immunodiagnosis ูุงููุง ูู ูุฏููู ูู
ุฑุง |
|
|
| 410 |
| 00:37:27,750 --> 00:37:31,090 |
| ูุงุญุฏ to detect antigen specific to tumor and cell |
|
|
| 411 |
| 00:37:31,090 --> 00:37:37,670 |
| ูู
ุฑุง ุงุชููู ูุชูููู
|
|
|
| 412 |
| 00:37:37,670 --> 00:37:42,000 |
| lost immune response to the tumorุทุจุนุง ุงูู tumor |
|
|
| 413 |
| 00:37:42,000 --> 00:37:46,220 |
| cell ุจู express cytoplasmic ุงู cell surface ุงู |
|
|
| 414 |
| 00:37:46,220 --> 00:37:50,100 |
| secreted product that are different in nature and |
|
|
| 415 |
| 00:37:50,100 --> 00:37:53,340 |
| or quantity from those produced by their normal |
|
|
| 416 |
| 00:37:53,340 --> 00:37:56,800 |
| counterpart ุทุจูุนู ุฌุฏุง tumor cell ุญุชู ุชูุฑุฒ ูุฐู |
|
|
| 417 |
| 00:37:56,800 --> 00:37:59,720 |
| ุงูุญุงุฌุงุช ุณูุงุก ูุงูุช cytoplasmic ุงู ุนูู ุงู cell |
|
|
| 418 |
| 00:37:59,720 --> 00:38:05,040 |
| surface ุงู ูู secreted product ุจุชุฎุชูู ุงุฎุชูุงู ููู |
|
|
| 419 |
| 00:38:05,040 --> 00:38:11,510 |
| ุนู ุงู normal counterpartุจุณุจุจ ุนุฏุฏ ุงูุงูุชุฌูููุงุช |
|
|
| 420 |
| 00:38:11,510 --> 00:38:13,850 |
| ุงูุตุญูุญุฉ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ |
|
|
| 421 |
| 00:38:13,850 --> 00:38:19,490 |
| ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู |
|
|
| 422 |
| 00:38:19,490 --> 00:38:22,970 |
| ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ |
|
|
| 423 |
| 00:38:22,970 --> 00:38:23,110 |
| ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ |
|
|
| 424 |
| 00:38:23,110 --> 00:38:23,130 |
| ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู |
|
|
| 425 |
| 00:38:23,130 --> 00:38:23,310 |
| ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ |
|
|
| 426 |
| 00:38:23,310 --> 00:38:37,910 |
| ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญ |
|
|
| 427 |
| 00:38:38,340 --> 00:38:42,300 |
| ูุญุตููุง ุนูู ู
ููููููู ุงูุงูุชูุจุงุฏู ูุฐู ุงูุงูุชูุจุงุฏู |
|
|
| 428 |
| 00:38:42,300 --> 00:38:46,320 |
| ูุณุชุฎุฏู
ูุง ูุงู
ู ุจูุณู
ููุง immunodiagnostic antibody |
|
|
| 429 |
| 00:38:46,320 --> 00:38:50,840 |
| for immunodiagnosis of a human tumor and their |
|
|
| 430 |
| 00:38:50,840 --> 00:38:58,700 |
| products these are widely used as reliable |
|
|
| 431 |
| 00:38:58,700 --> 00:39:05,660 |
| immunodiagnostic procedure ููุดูู ุงูุฃู
ุซูุฉ ุนูู ุฐูู |
|
|
| 432 |
| 00:39:06,870 --> 00:39:10,470 |
| ูุงููุง detection of myeloma protein produced by |
|
|
| 433 |
| 00:39:10,470 --> 00:39:14,570 |
| plasma cell tumor ุทุจุนุง ูู ุงู multiple myeloma ููุง |
|
|
| 434 |
| 00:39:14,570 --> 00:39:18,690 |
| ุจูุนุฑู ุงูู ูู antibody ุจุชุชููู ู
ู plasma cell ูู ูุฐู |
|
|
| 435 |
| 00:39:18,690 --> 00:39:22,990 |
| ุงูุญุงูุฉ ูุจุงูุชุงูู detection of these proteins or |
|
|
| 436 |
| 00:39:22,990 --> 00:39:28,430 |
| antibody can be diagnostic ุทุจุนุง ู
ุซุงู ุงุฎุฑ ูู |
|
|
| 437 |
| 00:39:28,430 --> 00:39:30,410 |
| multiple myeloma ุงูุถุง ูู light chain |
|
|
| 438 |
| 00:39:30,410 --> 00:39:34,230 |
| immunoglobulin ูุดูููุง ูู ุงู pensions protein ูู ุงู |
|
|
| 439 |
| 00:39:34,230 --> 00:39:37,430 |
| urineูุฐุง ุนุจุงุฑุฉ ุนู Diagnostic Criteria ุฃูุถูุง |
|
|
| 440 |
| 00:39:37,430 --> 00:39:42,450 |
| Indication ุนูู Plasma Cell Tumor ุงู
ุง ุงุชููู |
|
|
| 441 |
| 00:39:42,450 --> 00:39:45,450 |
| Detection ู Alpha-Feta Protein ูู ู
ู ูุนุฑู ุงู ุงู |
|
|
| 442 |
| 00:39:45,450 --> 00:39:48,630 |
| Alpha-Feta Protein ูู ุนุจุงุฑุฉ ุนู ุจุฑูุชูู ู
ูุฌูุฏ ูู ุงูู |
|
|
| 443 |
| 00:39:48,630 --> 00:39:53,650 |
| Fetal Serum ููู ุจุงูุชุงูู ุจุนุฏ ููุงุฏุฉ ุงู level ุจูููู |
|
|
| 444 |
| 00:39:53,650 --> 00:39:59,670 |
| ุนุงูู ููู ุจูุจุฏุฃ ููุฒู ุจุณุฑุนุฉ ูุบุงูุฉ ุนุดุฑูููุงูู ุฌุฑุงู
|
|
|
| 445 |
| 00:39:59,670 --> 00:40:05,450 |
| ุจูุฑู
ูู ุทุจุนุง ูู ุงูุชูุฑ ู
ู ูู ุญุงูุงุช ู
ุฑุถูุฉ ุฒู ุงู |
|
|
| 446 |
| 00:40:05,450 --> 00:40:10,370 |
| ovarian and testicular embryonal a non cancerous |
|
|
| 447 |
| 00:40:10,370 --> 00:40:15,410 |
| hepatic disorder ูุฐุง ุงู level of alpha-fetoprotein |
|
|
| 448 |
| 00:40:15,410 --> 00:40:23,170 |
| ุจูุฒูุฏ ูุงููุง ุงุฐุง ุฒุงุฏ ูุตู ุฎู
ุณู
ูุฉ ูุฃูู ูุงูู ุฌุฑุงู
|
|
|
| 449 |
| 00:40:23,170 --> 00:40:29,620 |
| ุจูุฑู
ูู ูุฐุง ุจูุนูู ุนูู ุงู ูู tumorุจููุชุฌ Alpha |
|
|
| 450 |
| 00:40:29,620 --> 00:40:35,480 |
| -Fetoprotein ูู
ุชุงุจุนุฉ ุงูู Alpha-Fetoprotein ุจูุนุฑููุง |
|
|
| 451 |
| 00:40:35,480 --> 00:40:41,080 |
| ุฅุฐุง ูุงู ุงูู tumor ุจุณูู ุฑูุฌูุดู ุฃู ุฑูุจุฑููุฌุดู CAA |
|
|
| 452 |
| 00:40:41,080 --> 00:40:44,920 |
| ุงุญูุง ูููุงูุง ุฏู ุนุจุงุฑุฉ ุนู ุงูู glycorrotine ูู ุงููุถุน |
|
|
| 453 |
| 00:40:44,920 --> 00:40:50,640 |
| ุงูุทุจูุนู ุจููุชุฌ by gastrointestinal tract ูุฎุตูุตุง ุงูู |
|
|
| 454 |
| 00:40:50,640 --> 00:40:56,550 |
| colonู ููู
ูุตูุฑ ุงูุฎูุงูุง ุณุฑุทุงููุฉ ุงูู CA ูุชู
ุฅุทูุงููุง |
|
|
| 455 |
| 00:40:56,550 --> 00:41:03,350 |
| ูู ุงูุฏู
ุฅุฐุง ุฒุงุฏุช ุงูุชุฑููุฒ ุนูู 2.5 ูุงูู ุฌุฑุงู
ุจูุฑู
ู |
|
|
| 456 |
| 00:41:03,350 --> 00:41:08,230 |
| ุจูุนูู ูู ู
ุงูู ูุงูุณู ุทุจุนุง ุงู high level ูู
ุงู ูุฌุฏูู |
|
|
| 457 |
| 00:41:08,230 --> 00:41:13,290 |
| ูู non cancerous disease |
|
|
| 458 |
| 00:41:13,290 --> 00:41:17,690 |
| ุฒู ุณูุฑูุณุฒ ู ุงู inflammatory disease of the |
|
|
| 459 |
| 00:41:17,690 --> 00:41:19,410 |
| intestinal tract and lung |
|
|
| 460 |
| 00:41:23,990 --> 00:41:30,070 |
| PCSA ุจุฑุงูุฌ ูุงูููููุซูู ู
ูุฌูุฏ ูู ุงูู ductal |
|
|
| 461 |
| 00:41:30,070 --> 00:41:36,330 |
| epithelial cells of the prostate ุฅุฐุง ูุงู ุชุฑููุฒ ุจู |
|
|
| 462 |
| 00:41:36,330 --> 00:41:40,030 |
| 8 ุฅูู 10 ูุงูู ูุฑุงู
ูู ุงูุจูุฏ ุจูุนูู ุฃูู ููู prostate |
|
|
| 463 |
| 00:41:40,030 --> 00:41:48,250 |
| cancer ุงู cancer antigen 125 CA125 |
|
|
| 464 |
| 00:41:50,660 --> 00:41:56,280 |
| ุทุจุนุง ูุฐุง ุจุฑุนุงู tumor marker ูุณุชุฎุฏู
for monitoring |
|
|
| 465 |
| 00:41:56,280 --> 00:42:01,880 |
| the therapy of ovarian cancer C125 |
|
|
| 466 |
| 00:42:01,880 --> 00:42:06,760 |
| ุฃูุถุง ุจูุฒูุฏ during peritoneal inflammatory process |
|
|
| 467 |
| 00:42:06,760 --> 00:42:10,600 |
| ููู other marker ูู ุจุฑุนุงู pan marker ุจูุณู
ู pan |
|
|
| 468 |
| 00:42:10,600 --> 00:42:17,410 |
| carcinoma marker ุงููู ูู P72.3ูู ุจุฑุนุงู
Monoclonal |
|
|
| 469 |
| 00:42:17,410 --> 00:42:23,730 |
| Antibody That Recognize All Carcinoma In Human ูู |
|
|
| 470 |
| 00:42:23,730 --> 00:42:27,710 |
| ุจุฑุนุงู
Monoclonal Antibody ุงุณุชุฎุฏู
ูุง ููู ุงูุชุนุฑู ุนูู |
|
|
| 471 |
| 00:42:27,710 --> 00:42:34,250 |
| ูู ุฃููุงุน ุงููุงุฑุณูููู
ุง ูู ุงูุฌุณู
ู
ู ุงูุณุจุจ ุจูุณุชุฎุฏู
ูุง |
|
|
| 472 |
| 00:42:34,250 --> 00:42:37,570 |
| ุทุจุนุง numerous attempts have been made to treat |
|
|
| 473 |
| 00:42:37,570 --> 00:42:41,730 |
| cancer in animal and human by immunological means |
|
|
| 474 |
| 00:42:42,280 --> 00:42:45,880 |
| ููู ููุฃุณู ุงูุดุฏูุฏ ุงูููู
ุงู immunotherapy ูู
ูุชู
|
|
|
| 475 |
| 00:42:45,880 --> 00:42:51,180 |
| ุชุญุฑูุฑูุง ูุชููู ุชุฌุงุฑุจ ู
ููุฏุฉ ููููุตุฑ ุณูุงุก ูุงูุช ุงุณุชุฎุฏู
ุช |
|
|
| 476 |
| 00:42:51,180 --> 00:42:54,740 |
| ูุญุงููุง ุงู ุงุณุชุฎุฏู
ุช in combination with chemotherapy |
|
|
| 477 |
| 00:42:54,740 --> 00:43:00,000 |
| and radiotherapy ุงู even surgery ุงูููู
currently |
|
|
| 478 |
| 00:43:00,000 --> 00:43:06,460 |
| ููู ูุนูู ู
ุฌู
ูุนุฉ ูุจูุฑุฉ ู
ู ุงูุฃุจุญุงุซ ูุงู ุงุณุชุฑุงุชูุฌูุงุช |
|
|
| 479 |
| 00:43:06,460 --> 00:43:12,110 |
| ูุถุนุชfor experimental immunotherapy of tumor |
|
|
| 480 |
| 00:43:12,110 --> 00:43:19,810 |
| ููุงุณุชุฎุฏุงู
ู ุทุจุนุง ุงุณุชุฎุฏู
ููุง ู
ู ุฎูุงู ุฏุฑุงุณุชูู
ูููููุฉ |
|
|
| 481 |
| 00:43:19,810 --> 00:43:27,430 |
| ูุณุงุฆู ุชูุดูุท ุงู ูุชู ุงูุฎูุงูุง ุงูู
ูุงุนูุฉ ุชูุดูุท ุงูุฎูุงูุง |
|
|
| 482 |
| 00:43:27,430 --> 00:43:30,750 |
| ุงูู
ูุงุนูุฉ ู ููููุฉ ูุชููุง ุงูุฎูุงูุง ุงูุณูุทุงููุฉ ู ุฏู |
|
|
| 483 |
| 00:43:30,750 --> 00:43:32,450 |
| ู
ููุงููุฒู
ุงุช ูููุง ุงุญูุง ุนุงุฑููููุง |
|
|
| 484 |
| 00:43:37,710 --> 00:43:47,360 |
| ุฃู
ุง ุจูุดุท ุงูู
ููุงูุฒู
ูุจุงูุชุงูู ุจูุฎุชู ุจุทุฑููุฉ ุฃูุถููุนูู |
|
|
| 485 |
| 00:43:47,360 --> 00:43:52,220 |
| ุงูุงููุณููุฉ ุฏู ูููุง ุจููุดุทูุง ุงู ู
ุญูู ุงููู ูู |
|
|
| 486 |
| 00:43:52,220 --> 00:43:56,500 |
| cytotoxic telephosite whatever ุญุชุชุทุฑู ุงูู ูุฐู |
|
|
| 487 |
| 00:43:56,500 --> 00:44:00,700 |
| ุงูู
ููุงููุฒู
ุงุช ูุงุญุฏ ูุงุญุฏ tumor specific monoclonal |
|
|
| 488 |
| 00:44:00,700 --> 00:44:08,340 |
| antibody ุงุณุชุฎุฏู
ูุง ุงูุช ุฏู anti CD20 ูุนูุงุฌ ุจุนุถ |
|
|
| 489 |
| 00:44:08,340 --> 00:44:14,920 |
| ุงููููููู
ุฉ Anti humanุฅูู ุจุฏูู ู
ู ุงูู Growth Factor |
|
|
| 490 |
| 00:44:14,920 --> 00:44:17,700 |
| Receptor for treatment of certain patients with |
|
|
| 491 |
| 00:44:17,700 --> 00:44:22,420 |
| breast and ovarian cancerุ ุทุจุนุง ูุฐู ุงูุงูุชูุจุงุฏู ูุงู |
|
|
| 492 |
| 00:44:22,420 --> 00:44:27,600 |
| ุจุฏูู Cytolysis either by Anky cell ู
ู ุฎูุงู ุงูู FC |
|
|
| 493 |
| 00:44:27,600 --> 00:44:34,260 |
| receptor ูู
ููุงูุฒู
ุงูู ADCC ุฃู by complement |
|
|
| 494 |
| 00:44:34,260 --> 00:44:39,740 |
| activation ูSurface Cytolysisattachment of toxin |
|
|
| 495 |
| 00:44:39,740 --> 00:44:45,000 |
| such as ricin or radioactive isotopes ุจุฑุจุทูุง ูุฐุง |
|
|
| 496 |
| 00:44:45,000 --> 00:44:51,460 |
| ุงู toxin ุจุงู antibody ู ุจูุญูููู ูู ุงูุฅูุณุงู |
|
|
| 497 |
| 00:44:51,460 --> 00:44:55,380 |
| ูุจุงูุชุงูู ุจูุจูู ูู
ุดู ูุบุฉ muscle specific for tumor |
|
|
| 498 |
| 00:44:55,380 --> 00:44:58,000 |
| cell ูุจุงูุชุงูู ุจูุตู ุงู tumor cell ู ููุงู ุจูุนู
ู |
|
|
| 499 |
| 00:44:58,000 --> 00:45:04,000 |
| direct killing ู ุงู cell xenogenic antibody ุทุจุนุง |
|
|
| 500 |
| 00:45:04,000 --> 00:45:10,120 |
| ุงุฎุฏูุง ู
ู ุงู mouseุงูุชูุจุงุฏู ุทุจุนุง ูู ุนุจุงุฑุฉ ุนู ูุงูุณ |
|
|
| 501 |
| 00:45:10,120 --> 00:45:16,160 |
| ุงูุชูุจุงุฏู ููู ุงู Fc portion ุจูุฑู ููู
ุจูููู ุฏู ุงููู |
|
|
| 502 |
| 00:45:16,160 --> 00:45:20,580 |
| ุชูููููุฌู ุฎูููุง humanize their constant region |
|
|
| 503 |
| 00:45:20,580 --> 00:45:26,860 |
| ูุจุงูุชุงูู ุญูู ุนุดุงู ูููููู
ุงู immunogenicity ุชุจุนุชู |
|
|
| 504 |
| 00:45:26,860 --> 00:45:31,560 |
| ุจุงู specific ุงูุชูุจุงุฏู ูุฐุง ุนุจุงุฑุฉ ุนู ุงูุชูุจุงุฏู |
|
|
| 505 |
| 00:45:31,560 --> 00:45:38,580 |
| ุงูุงูุชูุจุงุฏู ูู two fabูุงุญุฏุฉ ุฎูููุง ุทุจุนุง ุจุฑุถู by |
|
|
| 506 |
| 00:45:38,580 --> 00:45:42,240 |
| recombinant DNA technology ุงูู
ูุถูุน ูุงุญุฏุฉ ุฎูููุง |
|
|
| 507 |
| 00:45:42,240 --> 00:45:46,180 |
| specific for tumor antigen ูุงูุชุงููุฉ specific for |
|
|
| 508 |
| 00:45:46,180 --> 00:45:52,480 |
| ุงูุด for T cell ุงู NK cell ุงู whatever ู
ุงุดู |
|
|
| 509 |
| 00:45:52,480 --> 00:45:59,890 |
| ูุจุงูุชุงูู ูุฑุจูุงุงูู tumor cell ู
ู ุงูุฎููุฉ ุงูู
ูุงุนูุฉ |
|
|
| 510 |
| 00:45:59,890 --> 00:46:02,850 |
| ุงููู ูู ุงูู cytotoxic T- lymphocyte ุงู ุงูุงููู ุณูู |
|
|
| 511 |
| 00:46:02,850 --> 00:46:09,110 |
| ุงุฐุง ูุงู specific ูู Fc portion ุงู Fc receptor ุงููู |
|
|
| 512 |
| 00:46:09,110 --> 00:46:12,530 |
| ู
ูุฌูุฏ ุนูู ุณุทุญ ุงูุงููู ุณูู ูุจุงูุชุงูู ุงูุงููู ุณูู ุงูููู
|
|
|
| 513 |
| 00:46:12,530 --> 00:46:19,350 |
| ูุฑุจ both cells ุณูุงุก ุงู cytotoxic ุงู ุงูุงููู ุณูู ุดุฑุท |
|
|
| 514 |
| 00:46:19,350 --> 00:46:24,620 |
| ูุฌุงุญุงููู ูู ูุธููุชูุง ุงููู ูู cell to cell contact |
|
|
| 515 |
| 00:46:24,620 --> 00:46:27,700 |
| ููู
ูุฑูุจูุง ุงูุฎููุฉ ู
ู ุจุนุถ ูุจุงูุชุงูู ุจูุญุตู ูู direct |
|
|
| 516 |
| 00:46:27,700 --> 00:46:34,820 |
| license ุงู recombinant diffusion protein ุงููู ูู |
|
|
| 517 |
| 00:46:34,820 --> 00:46:41,260 |
| ุจุนุถ ุงูู
ุฑุงุช ุจูุนู
ููุง protein ุนุจุงุฑุฉ ุนู cytokine ู
ุน |
|
|
| 518 |
| 00:46:41,260 --> 00:46:46,550 |
| antitumor antibodyู ุจูุณู
ูู immunocytokine immuno |
|
|
| 519 |
| 00:46:46,550 --> 00:46:50,450 |
| ูุนูู ุงูุชุจุงุฏู ู cytokine ู
ู immunoglobulin ุทุจุนุง ู |
|
|
| 520 |
| 00:46:50,450 --> 00:46:54,250 |
| cytokine ู
ู cytokine ุจูุนู
ููููู
ุนูู ุดูู ุจุฑูุชูู ู |
|
|
| 521 |
| 00:46:54,250 --> 00:46:58,490 |
| ุจูููููุง as a fusion protein concentrate ูุจุงูุชุงูู |
|
|
| 522 |
| 00:46:58,490 --> 00:47:05,170 |
| ุจูุตูุฑ ุจูุดุชุบู ุนูู ุงู tumor cell ุจุดูู ุฃูุถู ุณุงุนุชู |
|
|
| 523 |
| 00:47:05,170 --> 00:47:12,280 |
| ุชูุณู ุชููููููุณุงุนุชู ุชุชุงุฎุฏ ู ุจุชุชูู
ู ุจุฑุงู
ุงุดู ูุฐู |
|
|
| 524 |
| 00:47:12,280 --> 00:47:17,940 |
| ุงูุฎูุงูุง ุชุณุชุทูุน ุงู ุชูุชู ู
ุจุงุดุฑุฉ ุงู tumor cell ู |
|
|
| 525 |
| 00:47:17,940 --> 00:47:23,380 |
| ุฎุตูุตุง ุงูู ุนูุฏูุง ุงููุฏุฑุฉ ุงููุง ุชุชููู cost emulatory |
|
|
| 526 |
| 00:47:23,380 --> 00:47:30,840 |
| molecule ุฒู CDAT86 ุงู cytokineุทุจุนุงู ุทุจุนุงู ุทุจุนุงู |
|
|
| 527 |
| 00:47:30,840 --> 00:47:38,980 |
| ุทุจุนุง |
|
|
| 528 |
| 00:47:38,980 --> 00:47:40,920 |
| ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง |
|
|
| 529 |
| 00:47:40,920 --> 00:47:44,620 |
| ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง |
|
|
| 530 |
| 00:47:47,550 --> 00:47:51,530 |
| ุจูุดุทููุง ุจุญูู ุงู ุงููdendritic cell already ู
ุฑุชุจุท |
|
|
| 531 |
| 00:47:51,530 --> 00:47:55,530 |
| ุจุงุด ู
ู ุฎูุงู MSC class 1 ู
ูููููููุฉ ุนูู ุงูุณุทุญุฉ ุจุงู |
|
|
| 532 |
| 00:47:55,530 --> 00:48:01,310 |
| antigenic peptide ุงู tumor antigen ูุจุงูุชุงูู ุจูุตูุฑ |
|
|
| 533 |
| 00:48:01,310 --> 00:48:08,410 |
| ุชุนุฑู ุงู ู
ุชูุดูุท ููุชูุงุชูู ุณุงูุชูุชูุณูู ููู
ููุณุงูุช ุงูุชุฑ |
|
|
| 534 |
| 00:48:08,410 --> 00:48:12,170 |
| ุงุฐุง ูุฐู highly efficient antigen presenting cell |
|
|
| 535 |
| 00:48:12,170 --> 00:48:18,490 |
| normally express high level of cell surfaceุจุงูุชุงูู |
|
|
| 536 |
| 00:48:18,490 --> 00:48:25,890 |
| ุจูุตูุฑ ููู ูุดุงุท ุงูุชุฑ ูู T-cells.Dentritic cells are |
|
|
| 537 |
| 00:48:25,890 --> 00:48:31,630 |
| either directly loaded ุจุงูุจูุจุชุงูุฏ ุฏู ุจูุญู
ููุง |
|
|
| 538 |
| 00:48:31,630 --> 00:48:37,550 |
| ู
ุจุงุดุฑุฉ ุจุงูุจูุจุชุงูุฏ ุงู tumor ุจูุจุชุงูุฏ ูุนูู ุฎูุงู tumor |
|
|
| 539 |
| 00:48:37,550 --> 00:48:40,730 |
| cell lysate ุงู |
|
|
| 540 |
| 00:48:41,970 --> 00:48:46,030 |
| ูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
| 541 |
| 00:48:46,030 --> 00:48:47,070 |
| ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
| 542 |
| 00:48:47,070 --> 00:48:51,950 |
| ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
| 543 |
| 00:48:51,950 --> 00:48:55,450 |
| ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
| 544 |
| 00:48:55,450 --> 00:49:00,250 |
| ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
| 545 |
| 00:49:00,250 --> 00:49:00,630 |
| ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
| 546 |
| 00:49:00,630 --> 00:49:03,210 |
| ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
| 547 |
| 00:49:03,210 --> 00:49:11,590 |
| ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏูTumor |
|
|
| 548 |
| 00:49:11,590 --> 00:49:14,270 |
| Antigen That Have Been Molecularly Characterized |
|
|
| 549 |
| 00:49:14,270 --> 00:49:19,070 |
| Active Vaccination ููุณูุง ูุณุชุฎุฏู
Recombinant |
|
|
| 550 |
| 00:49:19,070 --> 00:49:22,990 |
| Vaccine Which |
|
|
| 551 |
| 00:49:22,990 --> 00:49:26,770 |
| Have Been Developed Using Vaccinia Listeria Or |
|
|
| 552 |
| 00:49:26,770 --> 00:49:33,310 |
| Virus-Like Particle ุทุจุนุง ูุฐุง ุนุจุงุฑุฉ ุนู Active |
|
|
| 553 |
| 00:49:33,310 --> 00:49:41,480 |
| Immunization ู
ู ุฎูุงู ุฃูุถุงุญููู DNA ุจูุงุฒู
ูุฏ |
|
|
| 554 |
| 00:49:41,480 --> 00:49:48,080 |
| Constructs ุงููู ูู DNA Vaccine ุจูุณู
ูู ูุงููุฏู ู
ู |
|
|
| 555 |
| 00:49:48,080 --> 00:49:57,020 |
| ุฐูู ูู ุงู ูููู specific ูู tumor antigen and |
|
|
| 556 |
| 00:49:57,020 --> 00:50:05,300 |
| expressed by muscle cell ูุงูุง ุฏูุน ุนู Vaccine ู
ูุฌูุฏ |
|
|
| 557 |
| 00:50:05,300 --> 00:50:06,880 |
| ูู ุงู DNA |
|
|
| 558 |
| 00:50:13,350 --> 00:50:17,030 |
| which is unique to tumor antigen ูุนูู ูุจุงูุชุงูู |
|
|
| 559 |
| 00:50:17,030 --> 00:50:20,910 |
| ุจูุตูุฑ ูู expression ููุฐุง ุงู vaccine ูุฐุง ุงู tumor |
|
|
| 560 |
| 00:50:20,910 --> 00:50:24,670 |
| antigen ุงูุชุฑ ูุจุงูุชุงูู ุจูุจูู ููู ุชูุดูุท ููุด ููุฎูุงูุง |
|
|
| 561 |
| 00:50:24,670 --> 00:50:28,610 |
| ุงูู
ูุนูุฉ ุงูุชุฑ ูู ุจุนุถ ุงูุญุงูุงุช ุดู ุจูุนู
ููุง ุจูุญูููุง |
|
|
| 562 |
| 00:50:28,610 --> 00:50:35,430 |
| ุฌููุงุช ุงูุถุง ู
ุณุฆููุฉ ุนู ุชุตููุน cytokine ุฒู GMC SF IL2 |
|
|
| 563 |
| 00:50:35,430 --> 00:50:44,730 |
| IL12ูู ู
ุง ุฏููุง if they introduced ุจูุญุณููุง |
|
|
| 564 |
| 00:50:44,730 --> 00:50:47,150 |
| ุงู presentation of tumor antigen by the enteric |
|
|
| 565 |
| 00:50:47,150 --> 00:50:56,430 |
| cell at the site of injection augmentation |
|
|
| 566 |
| 00:50:56,430 --> 00:51:04,710 |
| of specific anticancer immunity ูู ุทุจุนุง ูุฐุง by |
|
|
| 567 |
| 00:51:04,710 --> 00:51:12,580 |
| stimulation of macrophageusing pcg ุงู ููุฑููู |
|
|
| 568 |
| 00:51:12,580 --> 00:51:20,080 |
| ุจูุชูุฑูุงู
ุจุงุฑููู ุทุจุนุง ู
ุซุงู ุนูู ุฐูู ูู ุงุณุชุฎุฏุงู
ุงู |
|
|
| 569 |
| 00:51:20,080 --> 00:51:24,060 |
| pcg for treating patient with residual superficial |
|
|
| 570 |
| 00:51:24,060 --> 00:51:28,480 |
| urinary bladder cancer ุจุญู ููู repeated |
|
|
| 571 |
| 00:51:28,480 --> 00:51:31,300 |
| installation of live mycobacterium into the |
|
|
| 572 |
| 00:51:31,300 --> 00:51:38,490 |
| bladder ู
ู ุฎูุงู ูุงุชูุชุฑ ุจุนุฏุงูุนู
ููุฉ ุจุนุฏ ู
ุง ูุนู
ููู ุงู |
|
|
| 573 |
| 00:51:38,490 --> 00:51:46,570 |
| section ููุง ุฃุซุจุชุช ูุฌุงุญ ู ุจุชุนุชุจุฑ treatment of |
|
|
| 574 |
| 00:51:46,570 --> 00:51:54,970 |
| choice for superficial bladder cancer ูุงุฒู
ูููู |
|
|
| 575 |
| 00:51:54,970 --> 00:52:01,630 |
| ุฎุงุฑุฌู synthetic molecule ุฃูุถุง ูุจูู ููุฒ ุฒู ุงูุจุนูุฑุงู |
|
|
| 576 |
| 00:52:01,630 --> 00:52:09,710 |
| ู ุงู copilumarูุงูู
ุงูู ุงูููุฏุฑูุฏ ุฏุงููุงููู ุฅูุซุงุฑ ูุนุฏุฉ |
|
|
| 577 |
| 00:52:09,710 --> 00:52:16,530 |
| these induce interferon production ูุงูุถุง ุจุนุถ ุงู |
|
|
| 578 |
| 00:52:16,530 --> 00:52:19,690 |
| herbal extracts have been used to stimulate the |
|
|
| 579 |
| 00:52:19,690 --> 00:52:28,650 |
| immune response ู
ููุง ุงูุฌูุณููุฌ ูุงูุฅูุดูููุณูุง |
|
|
| 580 |
| 00:52:31,840 --> 00:52:35,500 |
| ุงูู trials are also in progress on the effect of |
|
|
| 581 |
| 00:52:35,500 --> 00:52:40,820 |
| various cytokines ุฒู ุงู interferon alpha, beta, |
|
|
| 582 |
| 00:52:41,020 --> 00:52:47,220 |
| gamma ุนูู ุงู 1,2,2,3,4,5,12 tumor necrosis factor |
|
|
| 583 |
| 00:52:47,220 --> 00:52:54,540 |
| ู ุฃุฎุฑ ุฅู
ุง singly or in combination on tumor |
|
|
| 584 |
| 00:52:54,540 --> 00:52:56,600 |
| regression |
|
|
| 585 |
| 00:52:59,960 --> 00:53:04,680 |
| ุนุดุฑุฉ lag cell ู ุงู tumor infiltrate lymphocytes |
|
|
| 586 |
| 00:53:04,680 --> 00:53:09,680 |
| ุงูุถุง ุงุณุชุฎุฏู
ูู
ูู treatment of cancer with variable |
|
|
| 587 |
| 00:53:09,680 --> 00:53:15,020 |
| results lag cells are produced in vitro by |
|
|
| 588 |
| 00:53:15,020 --> 00:53:21,060 |
| cultivation ุจูุนู
ููููุง culturing ุจุงู IL-2 ู |
|
|
| 589 |
| 00:53:21,060 --> 00:53:25,000 |
| ุจูุนู
ููููุง reinfusion to the patient ู ุชุนู
ู |
|
|
| 590 |
| 00:53:25,000 --> 00:53:28,620 |
| dramatic improvement in the have been used |
|
|
| 591 |
| 00:53:34,260 --> 00:53:37,700 |
| ุฃูุถูุง ุงูู documented success ูุงูุช ุฃูุถูุง ู
ูุงูุฉ |
|
|
| 592 |
| 00:53:37,700 --> 00:53:42,940 |
| ุจุงุณุชุฎุฏุงู
tumor infiltrate lymphocyte ูู
ุง ููููุงูุง |
|
|
| 593 |
| 00:53:42,940 --> 00:53:48,280 |
| ูู
ุฑุถู ุนูุฏูู
melanoma ูุฌุฏูุง ุฃู ูุฐู ุงู lymphocyte |
|
|
| 594 |
| 00:53:48,280 --> 00:53:53,140 |
| ุทุจุนูุง ู
ู
ูู ุชุชุงุฎุฏ by removal from tumor biopsy |
|
|
| 595 |
| 00:53:53,140 --> 00:53:58,640 |
| expanded in vitro ูุนูู ูุจููููุง ูุฏููุง ููุจููููุง |
|
|
| 596 |
| 00:53:58,640 --> 00:54:04,380 |
| culturing ูู ูุฌูุฏ IL-2 ูุฑุฌุนููุง ุชุงูููุนูู ุงูู
ุฑูุถ |
|
|
| 597 |
| 00:54:04,380 --> 00:54:09,600 |
| ูุฌุฏูุง ุงูู ููู Anti-Tumor Activity Higher Many |
|
|
| 598 |
| 00:54:09,600 --> 00:54:20,900 |
| Times Than Lag Cell ู ูุฐู ูููุช ู
ู ุงูุนูุงุฌ |
|
|
| 599 |
| 00:54:20,900 --> 00:54:26,260 |
| tumor immunoprophylaxis ูุนูู ุนุดุงู ูู
ูุน ุงููู ูู |
|
|
| 600 |
| 00:54:26,260 --> 00:54:29,460 |
| prophylactic treatment for tumor |
|
|
| 601 |
| 00:54:35,430 --> 00:54:38,850 |
| ุจุงุณุชุฎุฏุงู
ุชูููุฉ ุงู
ููููุฉ ูุนูู ุงู
ููููุฉ ุถุฏ ุงูููุฑูุณ |
|
|
| 602 |
| 00:54:38,850 --> 00:54:42,590 |
| ุงูุงูููุฌููููู ูุงูุช |
|
|
| 603 |
| 00:54:42,590 --> 00:54:47,330 |
| ู
ูููู
ุฉ ูู ุงูููุจ ุญูุง ุงููู
ูู ุงูููุฑูุณ ุงูุงูููุฌููููู |
|
|
| 604 |
| 00:54:47,330 --> 00:54:52,850 |
| ุงูุถุง ุงู
ููููุฉ ุถุฏ ุนุถูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
| 605 |
| 00:54:52,850 --> 00:54:54,310 |
| ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
| 606 |
| 00:54:54,310 --> 00:54:55,950 |
| ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
| 607 |
| 00:54:55,950 --> 00:54:59,590 |
| ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
| 608 |
| 00:54:59,590 --> 00:54:59,670 |
| ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
| 609 |
| 00:54:59,670 --> 00:55:02,690 |
| ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญุฃู ุจูุนุทูุง tumor cell in |
|
|
| 610 |
| 00:55:02,690 --> 00:55:06,570 |
| which replication has been blocked ู
ุงููุด |
|
|
| 611 |
| 00:55:06,570 --> 00:55:10,290 |
| replication ุงู enzymatically modified surface |
|
|
| 612 |
| 00:55:10,290 --> 00:55:13,910 |
| membrane tumor cell ุงู extract of antigen from the |
|
|
| 613 |
| 00:55:13,910 --> 00:55:18,110 |
| surface of tumor cell ูููุง ุนุจุงุฑุฉ ุนู antigen ููู |
|
|
| 614 |
| 00:55:18,110 --> 00:55:22,840 |
| ู
ูุนูููุจุนูุด ุงูู ู
ุงูุตุงุฑุด ููู ุงููู ุงููู ูู |
|
|
| 615 |
| 00:55:22,840 --> 00:55:28,380 |
| replication ูู ุงู .. ูุจุงูุชุงูู ูู ุจุฑุน ุงู energy |
|
|
| 616 |
| 00:55:28,380 --> 00:55:34,980 |
| ุจูุนุทู ุนุณุงุณู ูููู
ุงูุฌูุงุฒ ุงูู
ูุงุนู ุนูุฏ ุงูุฅูุณุงู |
|
|
| 617 |
| 00:55:34,980 --> 00:55:37,880 |
| despite success in protection of experimental |
|
|
| 618 |
| 00:55:37,880 --> 00:55:42,720 |
| animal ูู ุงู animal ู
ุงุดู efficacy of menopreflexes |
|
|
| 619 |
| 00:55:42,720 --> 00:55:44,040 |
| for protection of human |
|
|
| 620 |
| 00:55:51,920 --> 00:55:57,020 |
| ุฃู ุญููููุฉ ุนูู ุงููููู
ุงู ุจุงููุณุจุฉ ููุชุนุงู
ู |
|
|
| 621 |
| 00:55:57,020 --> 00:56:01,600 |
| ุงูุจุฑููููุงูุชููู ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู |
|
|
| 622 |
| 00:56:01,600 --> 00:56:05,840 |
| ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู |
|
|
| 623 |
| 00:56:05,840 --> 00:56:05,920 |
| ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู |
|
|
| 624 |
| 00:56:05,920 --> 00:56:06,100 |
| ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู |
|
|
| 625 |
| 00:56:06,100 --> 00:56:09,740 |
| ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู ุงููููู
ุงู ุจุดูู |
|
|
| 626 |
| 00:56:09,740 --> 00:56:10,620 |
| ุงููููู
ุงู ุจุด |
|
|
|
|